[{"title": "C-Suite: Amgen's CEO Kevin Sharer - Jul. 9, 2009", "desc": null, "date": "09/07/2009", "link": "news.google.com/articles/CBMigwFodHRwczovL21vbmV5LmNubi5jb20vMjAwOS8wNy8wOC9uZXdzL2NvbXBhbmllcy9hbWdlbl9rZXZpbl9zaGFyZXJfYmlvdGVjaF9waGFybWFjZXV0aWNhbHMuZm9ydHVuZS9pbmRleC5odG0_cG9zdHZlcnNpb249MjAwOTA3MDkxMtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU5TV1pCV2xKV1ozRnhaRTlLVFJEOUFSakhBU2dCTWdZcEZaeXVrUW8=-w200-h112-p-df", "media": "CNN", "site": null, "reporter": "Geoffrey Colvin", "sentiment": "negative"}, {"title": "Amgen Down As Cuomo Alleges Massive Corruption, Kickbacks, And Fraud", "desc": null, "date": "30/10/2009", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vd3d3LmJ1c2luZXNzaW5zaWRlci5jb20vYW5kcmV3LWN1b21vLWdvZXMtYWZ0ZXItYW1nZW4tZm9yLWtpY2tiYWNrLXNjaGVtZS0yMDA5LTEw0gFdaHR0cHM6Ly93d3cuYnVzaW5lc3NpbnNpZGVyLmNvbS9hbmRyZXctY3VvbW8tZ29lcy1hZnRlci1hbWdlbi1mb3Ita2lja2JhY2stc2NoZW1lLTIwMDktMTA_YW1w?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWZURnBYZVVweWFFaDRRWFZxVFJEQ0FSaURBaWdCTWdhTmtwU0pPUWM=-w200-h112-p-df", "media": "Business Insider", "site": null, "reporter": "Lawrence Delevingne", "sentiment": "negative"}, {"title": "MedGenesis, Biovail to work on Parkinson's treatment", "desc": null, "date": "12/01/2010", "link": "news.google.com/articles/CBMieGh0dHBzOi8vd3d3LmN0dm5ld3MuY2EvbW9iaWxlL21lZGdlbmVzaXMtYmlvdmFpbC10by13b3JrLW9uLXBhcmtpbnNvbi1zLXRyZWF0bWVudC0xLjQ3MzA2Nz9jYWNoZT1waXFuZHF2a2g_Y2xpcElkPTM3NTc1NtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUtlRVpIVUcxeFFtNUNMVmR6VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "CTV News", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Top 10 Health Care ETFs", "desc": null, "date": "27/10/2011", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL2V0ZnMvdG9wLTEwLWhlYWx0aC1jYXJlLWV0ZnMtMTEyOTEyMzDSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVhhalZtYjFCc1lYZDVaeTAzVFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Morning Market Roundup (12/16/2011)", "desc": null, "date": "16/12/2011", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vMjQ3d2FsbHN0LmNvbS9pbnZlc3RpbmcvMjAxMS8xMi8xNi9tb3JuaW5nLW1hcmtldC1yb3VuZHVwLTEyMTYyMDExL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTVXR2g1YlhaNGVYQXlabWc1VFJDcUFSamNBU2dCTWdB=-w200-h112-p-df", "media": "24/7 Wall St.", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "ETF Showdown: Calling On Convertibles (CWB, CVRT) - Citigroup (NYSE:C), Amgen (NASDAQ:AMGN)", "desc": null, "date": "01/06/2012", "link": "news.google.com/articles/CBMiKGh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hcnRpY2xlLzI2MzQzOTPSASxodHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvMjYzNDM5Mw?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURURmRUVDJvdE5FOWFObVJ4VFJEaEFSamhBU2dCTWdZVms1THFPUWM=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Todd Shriber", "sentiment": "positive"}, {"title": "Amgen shutting down Epogen manufacturing in Longmont", "desc": null, "date": "08/08/2012", "link": "news.google.com/articles/CBMiWGh0dHBzOi8vd3d3LnRpbWVzY2FsbC5jb20vY2lfMjEyNjY0MjEvYW1nZW4tc2h1dHRpbmctZG93bi1lcG9nZW4tbWFudWZhY3R1cmluZy1sb25nbW9udC_SAV5odHRwczovL3d3dy50aW1lc2NhbGwuY29tLzIwMTIvMDgvMDgvYW1nZW4tc2h1dHRpbmctZG93bi1lcG9nZW4tbWFudWZhY3R1cmluZy1pbi1sb25nbW9udC9hbXAv?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNU1SVnA0VlhCNGVUVndhMjFmVFJDakFSaTBBaWdCTWdzQk1JWk1JQ2NXTW1tb2tn=-w200-h112-p-df", "media": "Longmont Times-Call", "site": null, "reporter": "Tony J. Kindelspire", "sentiment": "negative"}, {"title": "Onyx CEO Tony Coles will score $58M on Amgen deal", "desc": null, "date": "04/09/2013", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbS1hL29ueXgtY2VvLXRvbnktY29sZXMtd2lsbC1zY29yZS01OG0tb24tYW1nZW4tZGVhbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXpXVjh4UVdSclZ6VmhXalZRVFJDX0FSaklBU2dCTWdZcFJaaXRvUWc=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Amgen, Inc. (AMGN): Is Galena Biopharma Inc (GALE)'s Big Break ...", "desc": null, "date": "26/08/2013", "link": "news.google.com/articles/CBMipAFodHRwczovL3d3dy5pbnNpZGVybW9ua2V5LmNvbS9ibG9nL3RldmEtcGhhcm1hY2V1dGljYWwtaW5kdXN0cmllcy1sdGQtYWRyLXRldmEtYW1nZW4taW5jLWFtZ24taXMtZ2FsZW5hLWJpb3BoYXJtYS1pbmMtZ2FsZXMtYmlnLWJyZWFrLWp1c3QtYXJvdW5kLXRoZS1jb3JuZXItMjI4MzI2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJkNnNUthR2szVGtSTlFVaEZTM3BpVFJCZ0dLd0NLQUV5QXdGZ0FB=-w200-h112-p-df", "media": "Insider Monkey", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Top 10 Financial Tweets For Monday, August 26 - D.R. Horton (NYSE:DHI), Amgen (NASDAQ:AMGN)", "desc": null, "date": "26/08/2013", "link": "news.google.com/articles/CBMiKGh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hcnRpY2xlLzM4NjQ5MDXSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVBWQzFtWmxOUVpGQnljVFpLVFJETEFSajVBU2dCTWdPQk1oWQ=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Shopping on the Nasdaq", "desc": null, "date": "13/09/2013", "link": "news.google.com/articles/CBMiM2h0dHBzOi8vcHJvLnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL3Nob3BwaW5nLW5hc2RhcdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNU5NV2gzV0dnMmRUZFdkWGc0VFJEQ0FSaURBaWdCTWdB=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Ed Ponsi", "sentiment": "negative"}, {"title": "Pharma News: Vivus, Inc. (VVUS)'s Contract, Arena Pharmaceuticals, Inc. (ARNA) & Amgen, Inc. (AMGN)'s Financial ...", "desc": null, "date": "05/08/2013", "link": "news.google.com/articles/CBMikAFodHRwczovL3d3dy5pbnNpZGVybW9ua2V5LmNvbS9ibG9nL3BoYXJtYS1uZXdzLXZpdnVzLWluYy12dnVzcy1jb250cmFjdC1hcmVuYS1waGFybWFjZXV0aWNhbHMtaW5jLWFybmEtYW1nZW4taW5jLWFtZ25zLWZpbmFuY2lhbC1yZXN1bHRzLTIxNjEzNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdNR1pJUVRadmVqSkxVR294VFJDYkFSakVBaWdCTWdhUms0cHF2UVU=-w200-h112-p-df", "media": "Insider Monkey", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Affymax, once a promising biotech, is dissolving", "desc": null, "date": "24/06/2014", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FmZnltYXgtb25jZS1hLXByb21pc2luZy1iaW90ZWNoLWRpc3NvbHZpbmfSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlOMGRxWlVOaFowczBSM2MyVFJEUUFSaUFBU2dCTWdhTmhJekhQUVU=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "negative"}, {"title": "Celldex (CLDX) Up on Pilot Study Initiation on CDX-301", "desc": null, "date": "26/09/2014", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2NlbGxkZXgtY2xkeC1waWxvdC1zdHVkeS1pbml0aWF0aW9uLTIwMjAwMzY5NS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVJhVU41WjBKR1VrMVdWRkp3VFJDekFSaVpBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "NPS Pharmaceuticals Incurs Wider Q3 Loss, Revenues Miss", "desc": null, "date": "11/11/2014", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL25wcy1waGFybWFjZXV0aWNhbHMtaW5jdXJzLXdpZGVyLXEzLTE1NTAwMjc3OC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNWxia1JOVjFJMFVHdDJZemN3VFJDZkFSaTlBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan", "desc": null, "date": "26/11/2014", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvYWxleGlvbnMtYWx4bi1zb2xpcmlzLWdldHMtb3JwaGFuLTIxMTAwMjE5MS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNU5WWGg1VFdOMGVsSlNXRTFIVFJDb0FSaXNBaWdCTWdrQlFKS1dwT2JBUndJ=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen's Humira copy succeeds in skin disease trial", "desc": null, "date": "08/10/2014", "link": "news.google.com/articles/CBMiZmh0dHBzOi8vY2Euc3R5bGUueWFob28uY29tL25ld3MvYW1nZW5zLWh1bWlyYS1jb3B5LXN1Y2NlZWRzLXNraW4tZGlzZWFzZS10cmlhbC0xNjE1MzQwNDEtLWZpbmFuY2UuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTFMWFpoWkd4UlZHY3dNak4zVFJDb0FSaXNBaWdCTWdZTmFaS21xZ2M=-w200-h112-p-df", "media": "Yahoo Canada Shine On", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen launches delivery device for automatic administration of its blockbuster Neulasta", "desc": null, "date": "04/03/2015", "link": "news.google.com/articles/CBMieGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vci1kL2FtZ2VuLWxhdW5jaGVzLWRlbGl2ZXJ5LWRldmljZS1mb3ItYXV0b21hdGljLWFkbWluaXN0cmF0aW9uLW9mLWl0cy1ibG9ja2J1c3Rlci1uZXVsYXN0YdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW9SSE5EVGpReFpHaG1NbEJ5VFJENEFSaklBU2dCTWdZbFpJcU5OUVU=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Massive South S.F. biotech project from developer HCP breaks ground - San Francisco Business Times", "desc": null, "date": "04/02/2015", "link": "news.google.com/articles/CBMib2h0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vYmxvZy9iaW90ZWNoLzIwMTUvMDIvaGNwLWNvdmUtYXQtb3lzdGVyLXBvaW50LWJtci1hbWduLXRtby1jYWxpY28uaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUJNbHBSTUVOMU1IYzFZVFpzVFJDb0FSaXNBaWdCTWdZQlVZcU1NUVU=-w200-h112-p-df", "media": "San Francisco Business Times ", "site": null, "reporter": "Ron Leuty", "sentiment": "negative"}, {"title": "Is This a Biotech Bubble?", "desc": null, "date": "27/03/2015", "link": "news.google.com/articles/CBMiPWh0dHBzOi8vbW9uZXltb3JuaW5nLmNvbS8yMDE1LzAzLzI3L2lzLXRoaXMtYS1iaW90ZWNoLWJ1YmJsZS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDNOVFptYWpoUk0yaHVXWHBWVFJESEFSajlBU2dCTWdZRkVZNG1KZ1k=-w200-h112-p-df", "media": "Money Morning", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Global Yields and Debt Issues Hit Investment-Grade Bonds", "desc": null, "date": "13/05/2015", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvbmV3cy9nbG9iYWwteWllbGRzLWRlYnQtaXNzdWVzLWhpdC0xNzQzMDg2ODkuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDNiR1pFTFZaT0xUUmxSMlZOVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Announces Launch Of New Neulasta\u00ae (Pegfilgrastim) Delivery Kit", "desc": null, "date": "03/03/2015", "link": "news.google.com/articles/CBMia2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FtZ2VuLWFubm91bmNlcy1sYXVuY2gtb2YtbmV3LW5ldWxhc3RhJUMyJUFFLXBlZ2ZpbGdyYXN0aW0tZGVsaXZlcnkta2l00gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW1NRGd6Ukc5eGFXbExkRXhUVFJENkFSakpBU2dCTWdZbFpJcU5PUVU=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "FDA Approves Migraine Drug for Children", "desc": null, "date": "15/05/2015", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vd3d3LnBhaW5uZXdzbmV0d29yay5vcmcvc3Rvcmllcy8yMDE1LzUvMTUvZmRhLWFwcHJvdmVzLW1pZ3JhaW5lLWRydWctZm9yLWNoaWxkcmVu0gFkaHR0cHM6Ly93d3cucGFpbm5ld3NuZXR3b3JrLm9yZy9zdG9yaWVzLzIwMTUvNS8xNS9mZGEtYXBwcm92ZXMtbWlncmFpbmUtZHJ1Zy1mb3ItY2hpbGRyZW4_Zm9ybWF0PWFtcA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXJkRVZvZFVObk9USlFOVU54VFJDX0FSaUhBaWdCTWdB=-w200-h112-p-df", "media": "Pain News Network", "site": null, "reporter": "Pat Anson", "sentiment": "negative"}, {"title": "Biosimilar of Novartis' eye drug Lucentis launched in India", "desc": null, "date": "19/06/2015", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2Jpb3NpbWlsYXItb2Ytbm92YXJ0aXMtZXllLWRydWctbHVjZW50aXMtbGF1bmNoZWQtaW5kaWHSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWZkMWRuTm1oa1Yyd3lTR1V5VFJEaEFSamhBU2dCTWdhbEVvcE5rUXM=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "negative"}, {"title": "Zarxio, Novartis AG (ADR) (NYSE:NVS) Biosimilar Drug Gets Approved by FDA", "desc": null, "date": "11/03/2015", "link": "news.google.com/articles/CBMiZmh0dHA6Ly9zdG9ja3Mub3JnL2Jpb3BoYXJtYS96YXJ4aW8tbm92YXJ0aXMtYWctYWRyLW55c2VudnMtYmlvc2ltaWxhci1kcnVnLWdldHMtYXBwcm92ZWQtYnktZmRhLzI5MTA5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHRkblJMYkdOaWEwUXlWalEzVFJDeUFSaWNBaWdCTWdZUlU0RE5JUWM=-w200-h112-p-df", "media": "Stocks.org", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen's Repatha scores an exclusive with CVS", "desc": null, "date": "23/11/2015", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FtZ2VuLXMtcmVwYXRoYS1zY29yZXMtYW4tZXhjbHVzaXZlLWN2c9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXhSWFJIWVRWTmVVaGFSbWhuVFJDVUFSajZBU2dCTWdrTmNvYW5yYVpNOWdB=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "negative"}, {"title": "Amgen To Acquire Privately-Held Dezima Pharma", "desc": null, "date": "16/09/2015", "link": "news.google.com/articles/CBMiZWh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tdG8tYWNxdWlyZS1wcml2YXRlbHktaGVsZC1kZXppbWEtcGhhcm1hLTMwMDE0NDA0Ni5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTZkbEZKYmxwaWVqSlVUMGx4VFJDUUFSamVBaWdCTWdNQllBNA=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "U.K. cost gatekeeper says 'no' to Amgen's PCSK9 cholesterol fighter Repatha", "desc": null, "date": "18/11/2015", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcmVndWxhdG9yeS91LWstY29zdC1nYXRla2VlcGVyLXNheXMtbm8tdG8tYW1nZW4tcy1wY3NrOS1jaG9sZXN0ZXJvbC1maWdodGVyLXJlcGF0aGHSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXhSWFJIWVRWTmVVaGFSbWhuVFJDVUFSajZBU2dCTWdrTmNvYW5yYVpNOWdB=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "FDA swats down Pfizer's Xeljanz in plaque psoriasis", "desc": null, "date": "15/10/2015", "link": "news.google.com/articles/CBMiWGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcmVndWxhdG9yeS9mZGEtc3dhdHMtZG93bi1wZml6ZXItcy14ZWxqYW56LXBsYXF1ZS1wc29yaWFzaXPSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDRiRGhhZURJMVYySklURzkyVFJDbUFoaVdBU2dCTWdhSm80eUhRUVU=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Carly Helfand", "sentiment": "negative"}, {"title": "Why Amgen Is the Best S&P 500 Company", "desc": null, "date": "22/03/2016", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vb3Bpbmlvbi93aHktYW1nZW4taXMtdGhlLWJlc3Qtcy1hbXAtcC01MDAtY29tcGFueS0xMzUwMjQ5NNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNW1WVUYxZFRaaGVWZHZOblY0VFJDb0FSaXNBaWdCTWdNQnNBNA=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Rhonda Schaffler", "sentiment": "negative"}, {"title": "Amgen calls on TV actor 'McDreamy' to lead latest Breakaway from Cancer campaign", "desc": null, "date": "23/05/2016", "link": "news.google.com/articles/CBMifGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc2FsZXMtYW5kLW1hcmtldGluZy9hbWdlbi1jYWxscy10di1hY3Rvci1tY2RyZWFteS10by1sZWFkLWxhdGVzdC1icmVha2F3YXktZnJvbS1jYW5jZXItY2FtcGFpZ27SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVNkSE5EYlhFMFVVMXpabHBzVFJDb0FSaXNBaWdCTWdZcFZvenRLUWM=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Beth Bulik", "sentiment": "negative"}, {"title": "Biotech Stocks Earnings Preview: REGN, LGND, ECYT & More", "desc": null, "date": "03/05/2016", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvYmlvdGVjaC1zdG9ja3MtZWFybmluZ3MtcHJldmlldy1yZWduLTEzMDgwMTg0NC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNDVWV2t5Y0VoS1VURTBibTVPVFJDREFSaUFBeWdCTWdNSmNnWQ=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Regeneron cites success of PhIII anti-NGF pain drug after big rival bails out", "desc": null, "date": "02/05/2016", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL3JlZ2VuZXJvbi1hZHZhbmNlcy1pdHMtcGhpaWktYW50aS1uZ2YtcGFpbi1kcnVnLWFmdGVyLWEtYmlnLXJpdmFsLWJhaWxzLW91dNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTFRazVmZFhSWVNXNVdjVTlQVFJDb0FSaXNBaWdCTWdhcEE0cXZQUVk=-w200-h112-p-df", "media": "Fierce Biotech", "site": null, "reporter": "John Carroll", "sentiment": "negative"}, {"title": "Google unit stakes biotech claim with lease of entire Onyx campus - San Francisco Business Times", "desc": null, "date": "18/02/2016", "link": "news.google.com/articles/CBMicmh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vYmxvZy9iaW90ZWNoLzIwMTYvMDIvZ29vZ2xlLWFscGhhYmV0LXZlcmlseS1vbnl4LWFtZ2VuLWFtZ24tZ29vZy1jcmUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTRUSFJIZVd3MFUxa3dTeTFKVFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "San Francisco Business Times ", "site": null, "reporter": "Ron Leuty", "sentiment": "negative"}, {"title": "Regeneron CEO pushes back on pricing criticism of new gen cholesterol meds", "desc": null, "date": "13/05/2016", "link": "news.google.com/articles/CBMiYGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3JlZ2VuZXJvbi1jZW8tcHVzaGVzLWJhY2stY3JpdGljaXNtLXByaWNpbmctcGNzazktaW5oaWJpdG9yc9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNW1Na1ptY1U1WWRtTnZMVWR4VFJDb0FSaXNBaWdCTWdtaFVvcU5KYWhVTWdF=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "negative"}, {"title": "Three stock picks from Katherine Owen of Franklin Templeton", "desc": null, "date": "31/05/2016", "link": "news.google.com/articles/CBMilgFodHRwczovL2ZpbmFuY2lhbHBvc3QuY29tL2ludmVzdGluZy90cmFkaW5nLWRlc2svc3RvY2stcGljay13aHkta2F0aGVyaW5lLW93ZW4tb2YtdGVtcGxldG9uLWdsb2JhbC1lcXVpdHktZ3JvdXAtc2F5cy1zaW5vcGhhcm0taG9sZGluZy1jby1sdGQtaXMtYS1idXnSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDFORk5PTjAxT1RGOXFkRmRIVFJEQ0FSaURBaWdCTWdB=-w200-h112-p-df", "media": "Financial Post", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Otezla Captures Psoriasis and Psoriatic Arthritis Market Shares", "desc": null, "date": "14/05/2016", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL290ZXpsYS1jYXB0dXJlcy1wc29yaWFzaXMtcHNvcmlhdGljLWFydGhyaXRpcy0xMzA4MTQzMjguaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNWlZakJ0V0ZGVmFVZGxWbGRLVFJDeEFSaWNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Novartis spends on manufacturing, expecting big biosimilar payoff", "desc": null, "date": "20/06/2016", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9ub3ZhcnRpcy1zcGVuZHMtbWFudWZhY3R1cmluZy1leHBlY3RpbmctYmlnLWJpb3NpbWlsYXItcGF5b2Zm0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXphbTgyUlhobmRHeEpiMFpxVFJDb0FSaXNBaWdCTWdZZElJeXluQWs=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "negative"}, {"title": "Six Advanced Studies for Roche's Atezolizumab", "desc": null, "date": "27/03/2016", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3Mvc2l4LWFkdmFuY2VkLXN0dWRpZXMtcm9jaGUtYXRlem9saXp1bWFiLTA1MDQzNDE5Mi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXdlVzVYV1dnNWFuaFVhWEZGVFJDM0FSaVRBaWdCTWdZcE5aYk9JUWc=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Novartis' Sandoz aims for 5 biosim launches by 2020", "desc": null, "date": "20/06/2016", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL25vdmFydGlzLXNhbmRvei1haW1zLWZvci01LWJpb3NpbS1sYXVuY2hlcy1ieS0yMDIw0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTFWM2h4TkhwV1IwOW9XR1F6VFJDb0FSaXNBaWdCTWdZZElJcXluQWs=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Carly Helfand", "sentiment": "positive"}, {"title": "Kite Pharma Q4 Loss Wider but Focus Remains on KTE-C19", "desc": null, "date": "01/03/2016", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3Mva2l0ZS1waGFybWEtcTQtbG9zcy13aWRlci0xNDQwMDI4OTUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUhUbU4wVDNOSmNsTnVRemgwVFJDeEFSaWNBaWdCTWdZaEpwTHJIUWc=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "UPDATED: Pfizer closing Hospira plant in Colorado, 100 jobs to be lost", "desc": null, "date": "23/06/2016", "link": "news.google.com/articles/CBMiZGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9wZml6ZXItY2xvc2luZy1ob3NwaXJhLXBsYW50LWNvbG9yYWRvLTEwMC1qb2JzLXRvLWJlLWxvc3TSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDJWVkZwVEhaR2MwcHNOR1JYVFJDb0FSaXNBaWdCTWdhQlk1cU9wUWc=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "positive"}, {"title": "BioMarin's Naglazyme Sales Dipped by 31.3% Last Year", "desc": null, "date": "07/03/2016", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvYmlvbWFyaW4tbmFnbGF6eW1lLXNhbGVzLWRpcHBlZC0zMS0xMzA3MTAwNDguaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNHhMV3RKV1c4NE1FNXpSbTVtVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AstraZeneca to 'reshape' manufacturing as part of $1.5B cost-cutting effort", "desc": null, "date": "02/05/2016", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9hc3RyYXplbmVjYS1haW1zLXRvLXN0cmVhbWxpbmUtbWFudWZhY3R1cmluZ9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNDVSek5rZDNCcFVqaG5Ra05RVFJDb0FSaXNBaWdCTWdNQjhBQQ=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Sagonowsky", "sentiment": "negative"}, {"title": "AbbVie North Chicago plant has second fire", "desc": null, "date": "16/06/2016", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9hYmJ2aWUtbm9ydGgtY2hpY2Fnby1wbGFudC1oYXMtc2Vjb25kLWZpcmXSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUpNVmREYVc5Zk56UlRhazlFVFJDb0FSaXNBaWdCTWdZRkJwd0tsZ2s=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "negative"}, {"title": "Amgen (AMGN) Reports Positive Data on Prolia and Repatha", "desc": null, "date": "30/08/2016", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLXJlcG9ydHMtcG9zaXRpdmUtZGF0YS0xNDAzMDIxMjkuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHdWbGh4VTNZd1RtRlVWM1ZLVFJDWkFSaktBaWdCTWdhaE1wWXdtUWs=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "S&P To 2100? Goldman Weighs In - Amgen (NASDAQ:AMGN)", "desc": null, "date": "12/09/2016", "link": "news.google.com/articles/CBMiKGh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hcnRpY2xlLzg0NDY1MTDSASxodHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvODQ0NjUxMA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURURmRUVDJvdE5FOWFObVJ4VFJEaEFSamhBU2dCTWdZVms1THFPUWM=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Wayne Duggan", "sentiment": "negative"}, {"title": "Amgen picks up an edge for Repatha in duel with Sanofi and Regeneron", "desc": null, "date": "11/07/2016", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FtZ2VuLXBpY2tzLXVwLWVkZ2UtZm9yLXJlcGF0aGEtZHVlbC1zYW5vZmktYW5kLXJlZ2VuZXJvbtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHdSVU0xYkd4RlRWWjNiSFV3VFJDb0FSaXNBaWdCTWdhcFJZcnRKUVk=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "negative"}, {"title": "Amgen strikes $674M cardiovascular RNAi pact with Arrowhead", "desc": null, "date": "29/09/2016", "link": "news.google.com/articles/CBMidWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvZW1iYXJnby1saWZ0cy03LTMwYW0tZXQtYW1nZW4tc3RyaWtlcy02NzMtNW0tY2FyZGlvdmFzY3VsYXItcm5haS1wYWN0LWFycm93aGVhZNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHlSMlpOUldaeWVIVk1XbGhOVFJDb0FSaXNBaWdCTWdhSmNaQkxPUVk=-w200-h112-p-df", "media": "Fierce Biotech", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Aiming to shield $14B in sales, AbbVie smacks Amgen with a patent suit over Humira biosim", "desc": null, "date": "08/08/2016", "link": "news.google.com/articles/CBMic2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FpbWluZy10by1zaGllbGQtMTRiLXNhbGVzLWFiYnZpZS1zbWFja3MtYW1nZW4tYS1wYXRlbnQtc3VpdC1vdmVyLWh1bWlyYS1iaW9zaW3SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWZjbXRmWDNoeUxYSlFNVEpTVFJDb0FSaXNBaWdCTWdZTlFwcG1vZ2s=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "After $1 billion buyout of Flexus, team quickly builds Arcus Biosciences in Hayward - San Francisco Business Times", "desc": null, "date": "27/07/2016", "link": "news.google.com/articles/CBMidGh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vYmxvZy9iaW90ZWNoLzIwMTYvMDcvYXJjdXMtZmxleHVzLXRlcnJ5LXJvc2VuLWNhbmNlci1jZWxnLW52cy1ibXktYW1nbi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXhORkJ4YkRsWFdFcGFUM2RGVFJDb0FSaXJBaWdCTWdtRllwTEZwaWhGYmdF=-w200-h112-p-df", "media": "San Francisco Business Times ", "site": null, "reporter": "Ron Leuty", "sentiment": "positive"}, {"title": "Company News for July 29, 2016", "desc": null, "date": "29/07/2016", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vdWsubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2NvbXBhbnktbmV3cy1qdWx5LTI5LTIwMTYtMTQxMDAyOTI3Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNW1lVTlUVlUxM1dYWkdRMk5QVFJDeEFSaWNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo News UK", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "SF startup Carmot nabs discovery deal with Genentech", "desc": null, "date": "06/07/2016", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvc2Ytc3RhcnR1cC1jYXJtb3QtbmFicy1kaXNjb3ZlcnktZGVhbC1nZW5lbnRlY2jSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDFlRTV4U2tka056Rm1WUzExVFJDb0FSaXNBaWdCTWdrQmdJb0dNaWRVMUFB=-w200-h112-p-df", "media": "Fierce Biotech", "site": null, "reporter": "Stacy Lawrence", "sentiment": "negative"}, {"title": "The Big Short's Michael Burry Reveals His New Stock Picks", "desc": null, "date": "30/11/2016", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vd3d3Lmluc2lkZXJtb25rZXkuY29tL2Jsb2cvdGhlLWJpZy1zaG9ydHMtbWljaGFlbC1idXJyeS1yZXZlYWxzLWhpcy1uZXctc3RvY2stcGlja3MtNDkxNTEyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUtWQzFtWkdaTVRFbDVkSEZ4VFJEQ0FSaURBaWdCTWdrQkVJNkdHZWtza0FF=-w200-h112-p-df", "media": "Insider Monkey", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Japan's latest approvals include Praluent in second PCSK9 inhibitor", "desc": null, "date": "05/07/2016", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hLWFzaWEvamFwYW4tcy1sYXRlc3QtYXBwcm92YWxzLWluY2x1ZGUtcHJhbHVlbnQtc2Vjb25kLXBjc2s5LWluaGliaXRvctIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURiblJPZVVKeVJIQlNkalZoVFJDb0FSaXNBaWdCTWdZSndJaEtTUVU=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Unilife releases internal investigation results; finds little financial damage", "desc": null, "date": "25/10/2016", "link": "news.google.com/articles/CBMieGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vZHJ1Zy1kZWxpdmVyeS91bmlsaWZlLXJlbGVhc2VzLWludGVybmFsLWludmVzdGlnYXRpb24tcmVzdWx0cy1maW5kcy1saXR0bGUtZmluYW5jaWFsLWRhbWFnZdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXFYek5FZWxkS2NFcFFjMHh2VFJDbkFSaXRBaWdCTWdhZG81Uk11UVk=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Joseph Keenan", "sentiment": "negative"}, {"title": "Amgen An Undervalued Industry Leader", "desc": null, "date": "21/06/2017", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAxNy8wNi8yMS9hbWdlbi1hbi11bmRlcnZhbHVlZC1pbmR1c3RyeS1sZWFkZXIv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHlRME5DWTNSRmVrWXpaV1ZHVFJDTUFSanBBaWdCTWdZQkE0VHJGUTA=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": "David Trainer", "sentiment": "negative"}, {"title": "Why Amgen's Success Was a Big Disappointment", "desc": null, "date": "20/03/2017", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vd3d3LmZveGJ1c2luZXNzLmNvbS9tYXJrZXRzL3doeS1hbWdlbnMtc3VjY2Vzcy13YXMtYS1iaWctZGlzYXBwb2ludG1lbnTSAVNodHRwczovL3d3dy5mb3hidXNpbmVzcy5jb20vbWFya2V0cy93aHktYW1nZW5zLXN1Y2Nlc3Mtd2FzLWEtYmlnLWRpc2FwcG9pbnRtZW50LmFtcA?hl=en-US&gl=US&ceid=US%3Aen", "img": null, "media": "Fox Business", "site": null, "reporter": "Cory Renauer", "sentiment": "positive"}, {"title": "This Stock Turned $1,000 Into $1.53 Million in Less Than 33 Years", "desc": null, "date": "23/05/2017", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDE3LzA1LzIzL3RoaXMtc3RvY2stdHVybmVkLTEwMDAtaW50by0xNTMtbWlsbGlvbi1pbi1sZXNzLXRoLmFzcHjSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWtRUzFPYTA4eFozZFZabFYxVFJDM0FSaVRBaWdCTWdZSmRKaXVLUWc=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Sean Williams", "sentiment": "negative"}, {"title": "Pfizer's Xeljanz Combo Comparable to AbbVie's Humira", "desc": null, "date": "17/02/2017", "link": "news.google.com/articles/CBMiXmh0dHBzOi8vdWsubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL3BmaXplcnMteGVsamFuei1jb21iby1jb21wYXJhYmxlLWFiYnZpZXMtMTMxMzAxNzM5Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTJTMjF4VmpKVVZUaGlaVU51VFJDcEFSaXFBaWdCTWdrSkFZN2tHcXBqY0FF=-w200-h112-p-df", "media": "Yahoo News UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Deutsche Bank's Take On Big Pharma: 3 Buys And A Hold - Esperion Therapeutics (NASDAQ:ESPR), Gilead Scien", "desc": null, "date": "23/06/2017", "link": "news.google.com/articles/CBMiKGh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hcnRpY2xlLzk2NDY2NjfSASxodHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvOTY0NjY2Nw?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURURmRUVDJvdE5FOWFObVJ4VFJEaEFSamhBU2dCTWdZVms1THFPUWM=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Wayne Duggan", "sentiment": "negative"}, {"title": "Pharma CEOs Met With Trump But They Won't Give In to His Demands", "desc": null, "date": "31/01/2017", "link": "news.google.com/articles/CBMiQWh0dHBzOi8vZm9ydHVuZS5jb20vMjAxNy8wMS8zMS90cnVtcC1waGFybWEtY2Vvcy1tZWV0aW5nLWRlbWFuZHMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWlaVTFzVUMxTFVWWktURjh6VFJDZkFSaS1BaWdCTWdZQlE1d1FuUWs=-w200-h112-p-df", "media": "Fortune", "site": null, "reporter": "Sy Mukherjee", "sentiment": "negative"}, {"title": "Finding Bullish and Bearish Market Reversals", "desc": null, "date": "20/03/2017", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vcHJvLnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL2ZpbmRpbmctYnVsbGlzaC1hbmQtYmVhcmlzaC1tYXJrZXQtcmV2ZXJzYWxz0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNWZVR1JvV2twQ1UzRXpRMjV6VFJEQ0FSaURBaWdCTWdB=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Guy Ortmann", "sentiment": "negative"}, {"title": "Cochineal Insects Products: 7 Foods Made With Crushed Bugs", "desc": null, "date": "24/01/2017", "link": "news.google.com/articles/CBMiZWh0dHBzOi8vd3d3Lmluc2lkZXJtb25rZXkuY29tL2Jsb2cvY29jaGluZWFsLWluc2VjdHMtcHJvZHVjdHMtNy1mb29kcy1tYWRlLXdpdGgtY3J1c2hlZC1idWdzLTUyMTc5Ny800gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXVkMlYyZG10NlFreHRhRlJGVFJDbkFSaXRBaWdCTWdhVlZKREtLUWM=-w200-h112-p-df", "media": "Insider Monkey", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "3 ETFs to Watch Out for on Biotech Earnings", "desc": null, "date": "31/07/2017", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvMy1ldGZzLXdhdGNoLWJpb3RlY2gtZWFybmluZ3MtMDQyNjA0NjU4Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHhjRGd0TlVKMGIzTkNPVU5FVFJDM0FSaVRBaWdCTWdZRklKNWtuQW8=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "SPDR S&P Biotech ETF (XBI): The Quick Guide to XBI", "desc": null, "date": "16/09/2017", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAxNy8wOS9zcGRyLXNwLWJpb3RlY2gtZXRmLXhiaS10aGUtcXVpY2stZ3VpZGUv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNWtXSFZwUjBScFIwNDBYMXBoVFJDbUFSaXZBaWdCTWdB=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Todd Shriber", "sentiment": "negative"}, {"title": "Mylan Up on FDA Approval & Amazon's Rumored Pharmacy Interest", "desc": null, "date": "04/12/2017", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vbnoubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL215bGFuLWZkYS1hcHByb3ZhbC1hbWF6b24tYXBvcy0xNDQ2MDI2NzIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUdRbll6TlZWSk5raHpaUzFCVFJDM0FSaVRBaWdCTWdhbE5aanRvUWc=-w200-h112-p-df", "media": "Yahoo New Zealand News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Stock in Trouble, Despite Strong Results", "desc": null, "date": "21/03/2018", "link": "news.google.com/articles/CBMiPWh0dHBzOi8vZXdtaW50ZXJhY3RpdmUuY29tL2FtZ2VuLXN0b2NrLXRyb3VibGUtc3Ryb25nLXJlc3VsdHPSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXdSM0JsTWxwUVFuQnhZazh4VFJDb0FSaXNBaWdCTWdrQklJNkVKaVVlQXdN=-w200-h112-p-df", "media": "EWM Interactive", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Posts Fourth Quarter Numbers", "desc": null, "date": "02/02/2018", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1wb3N0cy1mb3VydGgtcXVhcnRlci1udW1iZXJzLTE1NDgyNzAxOC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNUtkMEZMYVRKSVVuVklOekZLVFJDckFSaW1BaWdCTWdPWkFRUQ=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "How a federal rule change helps this Peninsula drug company be 'masters of our own domain' - San Francisco ...", "desc": null, "date": "23/01/2018", "link": "news.google.com/articles/CBMibmh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDE4LzAxLzIzL2NvaGVydXMtY2hycy1hbWdlbi1hbWduLW5ldWxhc3RhLWJpb3NpbWlsYXJzLWNtcy5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHhjbEI0U2kxWE9YTjFhSGgzVFJDcEFSaXJBaWdCTWdZQkFZQUhrZ3c=-w200-h112-p-df", "media": "San Francisco Business Times ", "site": null, "reporter": "Ron Leuty", "sentiment": "negative"}, {"title": "Update to Mexico Natural Gas Pipeline Safety Rules Slated for Late August", "desc": null, "date": "09/05/2018", "link": "news.google.com/articles/CBMiamh0dHBzOi8vd3d3Lm5hdHVyYWxnYXNpbnRlbC5jb20vdXBkYXRlLXRvLW1leGljby1uYXR1cmFsLWdhcy1waXBlbGluZS1zYWZldHktcnVsZXMtc2xhdGVkLWZvci1sYXRlLWF1Z3VzdC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW1kekpKTkRKVk5XOTNZM2N3VFJDUUFSamRBaWdCTWdhTklwSnBtUWc=-w200-h112-p-df", "media": "Natural Gas Intelligence", "site": null, "reporter": "Peter De Montmollin", "sentiment": "negative"}, {"title": "Benzinga's Weekly Bulls & Bears: Amazon, Apple, GE, Twitter And More - Apple (NASDAQ:AAPL), Amazon.com (N", "desc": null, "date": "28/01/2018", "link": "news.google.com/articles/CBMiKWh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hcnRpY2xlLzExMDkxMjM20gEtaHR0cHM6Ly93d3cuYmVuemluZ2EuY29tL2FtcC9jb250ZW50LzExMDkxMjM2?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURURmRUVDJvdE5FOWFObVJ4VFJEaEFSamhBU2dCTWdZVms1THFPUWM=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Nelson Hem", "sentiment": "positive"}, {"title": "Why this Peninsula startup is primed for an $80.5 million IPO - San Francisco Business Times", "desc": null, "date": "24/05/2018", "link": "news.google.com/articles/CBMiZ2h0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDE4LzA1LzI0L2tlemFyLWxpZmUtc2NpZW5jZXMtYW1nZW4tYW1nbi1vbnl4LWx1cHVzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTFORGhuTVZWM1JuVmtUblpxVFJDVEFoaTNBU2dCTWdZZEU1WXNrUW8=-w200-h112-p-df", "media": "San Francisco Business Times ", "site": null, "reporter": "Ron Leuty", "sentiment": "negative"}, {"title": "Novartis' Lutathera Gets FDA Approval for Pancreatic Tumors", "desc": null, "date": "29/01/2018", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vdWsuc3R5bGUueWFob28uY29tL2ZpbmFuY2UvbmV3cy9ub3ZhcnRpcy1hcG9zLWx1dGF0aGVyYS1nZXRzLWZkYS0yMTE0MDk1NjguaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDRPVTVaZDJOTk1sTkJkMmhMVFJEQ0FSaURBaWdCTWdZWllJd3ZMUWs=-w200-h112-p-df", "media": "Yahoo Lifestyle UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia (denosumab) To Patients With Glucocorticoid ...", "desc": null, "date": "30/04/2018", "link": "news.google.com/articles/CBMitQFodHRwczovL3d3dy5teW5ld3NkZXNrLmNvbS9zZS9hbWdlbi9wcmVzc3JlbGVhc2VzL2FtZ2VuLXJlY2VpdmVzLXBvc2l0aXZlLWNobXAtb3Bpbmlvbi10by1leHBhbmQtdXNlLW9mLXByb2xpYS1kZW5vc3VtYWItdG8tcGF0aWVudHMtd2l0aC1nbHVjb2NvcnRpY29pZC1pbmR1Y2VkLW9zdGVvcG9yb3Npcy0yNDkzNjc20gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFORVpEVTFneGRFOXBNMnBwVFJDb0FSaXNBaWdCTWdZQlE0UUpJZ2c=-w200-h112-p-df", "media": "Mynewsdesk", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Submits Supplemental Biologics License Application For Nplate\u00ae (romiplostim)", "desc": null, "date": "19/12/2018", "link": "news.google.com/articles/CBMihwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLXN1Ym1pdHMtc3VwcGxlbWVudGFsLWJpb2xvZ2ljcy1saWNlbnNlLWFwcGxpY2F0aW9uLWZvci1ucGxhdGUtcm9taXBsb3N0aW0tMzAwNzY5MTMzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVFiSGxSWTBvM05uQm1aVlZKVFJDaUFSaTJBaWdCTWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The 7 Best Biotech Stocks for Investors Who Hate Risk", "desc": null, "date": "20/09/2018", "link": "news.google.com/articles/CBMidGh0dHBzOi8vd3d3LmtpcGxpbmdlci5jb20vc2xpZGVzaG93L2ludmVzdGluZy90MDUyLXMwMDEtNy1iZXN0LWJpb3RlY2gtc3RvY2tzLWZvci1pbnZlc3RvcnMtd2hvLWhhdGUtcmlzay9pbmRleC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXlNVWx0Umw5bFNIRTBURlZSVFJDeEFSaWNBaWdCTWdPQmRBWQ=-w200-h112-p-df", "media": "Kiplinger's Personal Finance", "site": null, "reporter": "James Brumley", "sentiment": "positive"}, {"title": "AstraZeneca's Asthma Drug Gets Breakthrough Therapy Status", "desc": null, "date": "07/09/2018", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2FzdHJhemVuZWNhLWFwb3MtYXN0aG1hLWRydWctZ2V0cy0xNDIxMDI0MzcuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWtObkp1WkdaQmVHUmlTVlZZVFJELUFSakhBU2dCTWdZZGNvTHNNUVk=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Why a kidney disease drug approval in China is just the start for this S.F. company - San Francisco Business Times", "desc": null, "date": "18/12/2018", "link": "news.google.com/articles/CBMibGh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDE4LzEyLzE4L2ZpYnJvZ2VuLWNoaW5hLXJveGFkdXN0YXQta2lkbmV5LWNrZC1mZ2VuLWFtZ24uaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTZWbkpOU25oTVNTMTBOMjloVFJDb0FSaXJBaWdCTWdZQmtJd3N1Z1U=-w200-h112-p-df", "media": "San Francisco Business Times ", "site": null, "reporter": "Ron Leuty", "sentiment": "positive"}, {"title": "AbbVie's Stock Hit By Citron Tweet - AbbVie (NYSE:ABBV)", "desc": null, "date": "19/07/2018", "link": "news.google.com/articles/CBMiKWh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hcnRpY2xlLzEyMDQ1MzY00gEtaHR0cHM6Ly93d3cuYmVuemluZ2EuY29tL2FtcC9jb250ZW50LzEyMDQ1MzY0?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURURmRUVDJvdE5FOWFObVJ4VFJEaEFSamhBU2dCTWdZVms1THFPUWM=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Wayne Duggan", "sentiment": "negative"}, {"title": "AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib", "desc": null, "date": "21/12/2018", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vdWsuc3R5bGUueWFob28uY29tL2ZpbmFuY2UvbmV3cy9hYmJ2aWUtYWJidi1zZWVrcy1hcHByb3ZhbC1yYS0xOTUyMDc0NzcuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTVWVkIwZWtOeUxUWXhhbXRMVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Lifestyle UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "New Class of Migraine Drug Creates Four-Way Pharma Development Race - Eli Lilly and Co (NYSE:LLY), iShare", "desc": null, "date": "06/09/2018", "link": "news.google.com/articles/CBMiKWh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hcnRpY2xlLzEyMjg0NTgw0gEtaHR0cHM6Ly93d3cuYmVuemluZ2EuY29tL2FtcC9jb250ZW50LzEyMjg0NTgw?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURURmRUVDJvdE5FOWFObVJ4VFJEaEFSamhBU2dCTWdZVms1THFPUWM=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "shanthi rexaline", "sentiment": "positive"}, {"title": "Amgen: This Industry Leader Remains Undervalued", "desc": null, "date": "30/01/2019", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAxOS8wMS8zMC9hbWdlbi10aGlzLWluZHVzdHJ5LWxlYWRlci1yZW1haW5zLXVuZGVydmFsdWVkL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVVhMGgxTVROUFpYYzFXVkp1VFJEQ0FSaURBaWdCTWdZVk1vRXJYUUk=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": "David Trainer", "sentiment": "negative"}, {"title": "Benzinga's Top Upgrades, Downgrades For May 23, 2019 - Amgen (NASDAQ:AMGN)", "desc": null, "date": "23/05/2019", "link": "news.google.com/articles/CBMiKWh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hcnRpY2xlLzEzNzk2Mjgx0gEtaHR0cHM6Ly93d3cuYmVuemluZ2EuY29tL2FtcC9jb250ZW50LzEzNzk2Mjgx?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURURmRUVDJvdE5FOWFObVJ4VFJEaEFSamhBU2dCTWdZVms1THFPUWM=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Lisa Levin", "sentiment": "negative"}, {"title": "FDA Approves Amgen And Allergan's KANJINTI\u2122 (trastuzumab-anns), A Biosimilar To Herceptin\u00ae (trastuzumab)", "desc": null, "date": "13/06/2019", "link": "news.google.com/articles/CBMimAFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2ZkYS1hcHByb3Zlcy1hbWdlbi1hbmQtYWxsZXJnYW5zLWthbmppbnRpLXRyYXN0dXp1bWFiLWFubnMtYS1iaW9zaW1pbGFyLXRvLWhlcmNlcHRpbi10cmFzdHV6dW1hYi0zMDA4Njc2MDMuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXpWVGhGT0dOTFZYSjFlbGw0VFJDaUFSaTJBaWdCTWdZQm9KTEdRQWM=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Health Care Sector Update for 03/18/2019: DERM, TORC, SLNO, JNJ, PFE, ABT, MRK, AMGN", "desc": null, "date": "18/03/2019", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvaGVhbHRoLWNhcmUtc2VjdG9yLXVwZGF0ZS0wMzE4MjAxOS1kZXJtLXRvcmMtc2xuby1qbmotcGZlLWFidC1tcmstYW1nbi0yMDE5LTAzLTE40gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU5TSFJGVkhNeFpuY3pNVGRHVFJDbkFSaXRBaWdCTWdZUlFJZ3dPUVE=-w200-h112-p-df", "media": "Nasdaq", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Falls 5%", "desc": null, "date": "30/01/2019", "link": "news.google.com/articles/CBMiQ2h0dHBzOi8vdWsubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2FtZ2VuLWZhbGxzLTUtMTAxNjA3MTUwLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUxaRUZNY20xcVRIbEVMVVJwVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo News UK", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Medicines Company Rallies On Positive LDL Cholesterol Study Results", "desc": null, "date": "20/05/2019", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9tZWRpY2luZXMtY29tcGFueS1yYWxsaWVzLXBvc2l0aXZlLWxkbC0xMzQyMDkxMDkuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNVllV2RmUVRJMGFGb3dlRzlTVFJDM0FSaVRBaWdCTWdtUkpJenBRZVZycFFJ=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "shanthi rexaline", "sentiment": "negative"}, {"title": "Using Free Cash Flow To Find Value With This ETF", "desc": null, "date": "01/05/2019", "link": "news.google.com/articles/CBMia2h0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAxOS8wNS8wMS91c2luZy1mcmVlLWNhc2gtZmxvdy10by1maW5kLXZhbHVlLXdpdGgtdGhpcy1ldGYv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVlVSHB2TlZZMFpsRmtRM0V4VFJDM0FSaVRBaWdCTWdhUjVvb3BSZ1U=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": "David Trainer", "sentiment": "negative"}, {"title": "Stocks - Apple, AMD, Boeing Surge in Premarket, AT&T, Amgen Drop", "desc": null, "date": "30/01/2019", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vdWsuc3R5bGUueWFob28uY29tL2ZpbmFuY2UvbmV3cy9zdG9ja3MtYXBwbGUtYW1kLWJvZWluZy1zdXJnZS0wODE4MDAwNzUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNWhNVU5VWkZOT1UwWTVNMDV4VFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Lifestyle UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "FDA Approves Amgen's AVSOLA\u2122 (infliximab-axxq), For The Same Indications As Remicade\u00ae (infliximab)", "desc": null, "date": "06/12/2019", "link": "news.google.com/articles/CBMikgFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2ZkYS1hcHByb3Zlcy1hbWdlbnMtYXZzb2xhLWluZmxpeGltYWItYXh4cS1mb3ItdGhlLXNhbWUtaW5kaWNhdGlvbnMtYXMtcmVtaWNhZGUtaW5mbGl4aW1hYi0zMDA5NzA3ODUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUNNMU14WjJ0clVsOWhVVWhSVFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Q2 2019 earnings report", "desc": null, "date": "30/07/2019", "link": "news.google.com/articles/CBMiR2h0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vYW1nZW4tYW1nbi1zdG9jay1xMi0yMDE5LWVhcm5pbmdzLXJlc3VsdHMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVZkR1V4Wnpod1VEQnFVQzFMVFJDa0FoaXRBU2dCTWdZQlFZYlNuQWM=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Discovery Of Amgen's Novel Investigational KRAS(G12C) Inhibitor AMG 510 Published In Nature", "desc": null, "date": "30/10/2019", "link": "news.google.com/articles/CBMilAFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3RoZS1kaXNjb3Zlcnktb2YtYW1nZW5zLW5vdmVsLWludmVzdGlnYXRpb25hbC1rcmFzZzEyYy1pbmhpYml0b3ItYW1nLTUxMC1wdWJsaXNoZWQtaW4tbmF0dXJlLTMwMDk0ODY2NC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXpNbkJ5YzJwdGJWaDFTeTF1VFJER0FSai1BU2dCTWdhWmM1Q05yUVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Does Amgen Inc.'s (NASDAQ:AMGN) CEO Salary Compare Well With Others?", "desc": null, "date": "30/10/2019", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vY2Euc3R5bGUueWFob28uY29tL3N0eWxlL2RvZXMtYW1nZW4taW5jLW5hc2RhcS1hbWduLTEwMzMxMTA2OC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHpWSEJFZFVWSVNGTk5TMWRvVFJDSEFSajFBaWdCTWdhQkFZYlZnQXc=-w200-h112-p-df", "media": "Yahoo Canada Shine On", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "World's largest biotech company to move up to BioMed's big South City project - San Francisco Business Times", "desc": null, "date": "09/12/2019", "link": "news.google.com/articles/CBMibWh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDE5LzEyLzA5L2FtZ2VuLWJpb21lZC1nYXRld2F5LW9mLXBhY2lmaWMtYW1nbi1ibGFja3N0b25lLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTFZbVZJUlV4WGRqZEhPVzFhVFJDb0FSaXJBaWdCTWdNQm9RWQ=-w200-h112-p-df", "media": "San Francisco Business Times ", "site": null, "reporter": "Ron Leuty", "sentiment": "positive"}, {"title": "Better Buy: Amgen vs. Pfizer", "desc": null, "date": "04/12/2019", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDE5LzEyLzA0L2JldHRlci1idXktYW1nZW4tdnMtcGZpemVyLmFzcHjSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDVOV0ZZV1dJeGJVTlRSRlp6VFJDM0FSaVVBaWdCTWdhQkFvaUNqUWs=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "George Budwell", "sentiment": "negative"}, {"title": "Amgen Wins Patent Case On Enbrel\u00ae (etanercept)", "desc": null, "date": "09/08/2019", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4td2lucy1wYXRlbnQtY2FzZS1vbi1lbmJyZWwtZXRhbmVyY2VwdC0zMDA4OTk1OTAuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Bristol Myers Squibb (BMY) announces Amgen's (AMGN) buy out of Celgene's (CELG) Otezla", "desc": null, "date": "26/08/2019", "link": "news.google.com/articles/CBMiogFodHRwczovL25ld3MuYWxwaGFzdHJlZXQuY29tL2FtZ2VuLWFtZ24tdG8tYWNxdWlyZS1jZWxnZW5lcy1jZWxnLW90ZXpsYS1mb3ItMTMtNC1iaWxsaW9uLWJteS1icmlzdG9sLW15ZXJzLXNxdWliYi1jZWxnZW5lLW1lcmdlci1leHBlY3RlZC10by1jbG9zZS1ieS1lbmQtb2YtMjAxOS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZXa0YwTFhKNlgyOUhRMUk1VFJDZkFSaS1BaWdCTWdhQlU1SWlyd2M=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Stocks Hold Against Resistance", "desc": null, "date": "09/12/2019", "link": "news.google.com/articles/CBMiQ2h0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vc3RvY2tzLWhvbGQtYWdhaW5zdC1yZXNpc3RhbmNlLTQ3Nzg2MTDSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTBZbnBoU2pWVWNVMWFXRXcxVFJDbkFSaXRBaWdCTWdrRkFZYW1pZW84RXdF=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Gordon Scott", "sentiment": "negative"}, {"title": "Amgen's Breakaway from Cancer\u00ae", "desc": null, "date": "16/12/2019", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vd3d3Lm11bHRpdnUuY29tL3BsYXllcnMvRW5nbGlzaC84NTQwOTUxLWFtZ2VuLWJyZWFrYXdheS1mcm9tLWNhbmNlci1uZXctdmlkZW8v0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDBlbWR0VUZwdFVFOUhkR3cwVFJDR0FSajVBaWdCTWdZaGhJaXMwUU0=-w200-h112-p-df", "media": "MultiVu", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "BeiGene Announces Global Strategic Oncology Collaboration with Amgen", "desc": null, "date": "31/10/2019", "link": "news.google.com/articles/CBMijwFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9lbi9uZXdzLXJlbGVhc2UvMjAxOS8xMC8zMS8xOTM5MDgyLzAvZW4vQmVpR2VuZS1Bbm5vdW5jZXMtR2xvYmFsLVN0cmF0ZWdpYy1PbmNvbG9neS1Db2xsYWJvcmF0aW9uLXdpdGgtQW1nZW4uaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iKkNnNHdNbTlUTVZWcVgwdzJlVzQzVFJCdUdLd0NLQUV5QmdGUWtBUWpDUQ=-w200-h112-p-df", "media": "GlobeNewswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen's Osteoporosis Drug Evenity Gets Approval in Europe", "desc": null, "date": "12/12/2019", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2FtZ2Vucy1vc3Rlb3Bvcm9zaXMtZHJ1Zy1ldmVuaXR5LWdldHMtMTQzNjAyODczLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iKkNnNHhOa2QwVHpsV1pVaHpVM2RCVFJCOUdKUURLQUV5QmdrQ2lvVzVCUQ=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen And Allergan's MVASI\u2122 (bevacizumab-awwb) And KANJINTI\u2122 (trastuzumab-anns) Now Available In The ...", "desc": null, "date": "18/07/2019", "link": "news.google.com/articles/CBMiowFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLWFuZC1hbGxlcmdhbnMtbXZhc2ktYmV2YWNpenVtYWItYXd3Yi1hbmQta2FuamludGktdHJhc3R1enVtYWItYW5ucy1ub3ctYXZhaWxhYmxlLWluLXRoZS11bml0ZWQtc3RhdGVzLTMwMDg4Nzg3MS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Earnings, Revenue Beat in Q3", "desc": null, "date": "29/10/2019", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2FtZ2VuLWVhcm5pbmdzLXJldmVudWUtYmVhdC1xMy0xNjA0MDA0MDUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUJTWEJxTURCU09IQTRMVUkyVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Pfizer's (PFE) Avastin Biosimilar Zirabev Gets FDA Approval", "desc": null, "date": "01/07/2019", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vdWsuc3R5bGUueWFob28uY29tL2ZpbmFuY2UvbmV3cy9wZml6ZXJzLXBmZS1hdmFzdGluLWJpb3NpbWlsYXItemlyYWJldi0xMzQzMDE1MTIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXdPRmRzU2twM1ltUTVSRzlMVFJDeUFSaWJBaWdCTWdhRklZd0tuUVk=-w200-h112-p-df", "media": "Yahoo Lifestyle UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Completes Acquisition Of Otezla\u00ae (apremilast)", "desc": null, "date": "21/11/2019", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tY29tcGxldGVzLWFjcXVpc2l0aW9uLW9mLW90ZXpsYS1hcHJlbWlsYXN0LTMwMDk2MjkzMi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Are Amgen and Gilead Sciences Better Buys After Second-Quarter Earnings?", "desc": null, "date": "31/07/2019", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vYXUubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2FtZ2VuLWdpbGVhZC1zY2llbmNlcy1iZXR0ZXItYnV5cy0xNTA5MDA1MDQuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDNURWhGV210b09Xc3pXSGt6VFJDeEFSaWRBaWdCTWdhbFpZTHRzUVE=-w200-h112-p-df", "media": "Yahoo News Australia", "site": null, "reporter": "George Budwell", "sentiment": "negative"}, {"title": "Lilly Gets FDA Approval for New Oral Tablets for Migraine", "desc": null, "date": "14/10/2019", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vYXUubGlmZXN0eWxlLnlhaG9vLmNvbS9saWZlc3R5bGUvbGlsbHktZ2V0cy1mZGEtYXBwcm92YWwtb3JhbC0xNDE0MDIzODcuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDNURWhGV210b09Xc3pXSGt6VFJDeEFSaWRBaWdCTWdhbFpZTHRzUVE=-w200-h112-p-df", "media": "Yahoo Lifestyle Australia", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Horizon's (HZNP) Eye Disease Drug Gets FDA's Priority Review", "desc": null, "date": "10/09/2019", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vbnoubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2hvcml6b25zLWh6bnAtZXllLWRpc2Vhc2UtZHJ1Zy0xMTU5MTEyMjYuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXJlWE5ETlhaTVpsSnpkMnN6VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo New Zealand News", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen Stock Looks to Break Out After Analyst Upgrade", "desc": null, "date": "30/03/2020", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vYW1nZW4tbG9va3MtdG8tYnJlYWtvdXQtYWZ0ZXItYW5hbHlzdC11cGdyYWRlLTQ4MDEyODTSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVVOV3BSTW5oRmVuUTBRVFE0VFJDNUFSaVJBaWdCTWdPQk1SQQ=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Justin Kuepper", "sentiment": "negative"}, {"title": "Amgen Reports Fourth Quarter And Full Year 2019 Financial Results", "desc": null, "date": "30/01/2020", "link": "news.google.com/articles/CBMieWh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tcmVwb3J0cy1mb3VydGgtcXVhcnRlci1hbmQtZnVsbC15ZWFyLTIwMTktZmluYW5jaWFsLXJlc3VsdHMtMzAwOTk2NTA1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Better Buy: Biogen vs. Amgen", "desc": null, "date": "15/03/2020", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzAzLzE1L2JldHRlci1idXktYmlvZ2VuLXZzLWFtZ2VuLmFzcHjSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXhXa0Y0TkdGc2VWVnplR2w2VFJDM0FSaVRBaWdCTWdZSk1vYlZvQWc=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Adria Cimino", "sentiment": "negative"}, {"title": "Amgen Stock Falls 3%", "desc": null, "date": "15/04/2020", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vdWsubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2FtZ2VuLXN0b2NrLWZhbGxzLTMtMTEyMjAwNzA5Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUJTWEJxTURCU09IQTRMVUkyVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo News UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China", "desc": null, "date": "02/01/2020", "link": "news.google.com/articles/CBMikQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLWNvbW1lbmNlcy1zdHJhdGVnaWMtY29sbGFib3JhdGlvbi13aXRoLWJlaWdlbmUtdG8tZXhwYW5kLW9uY29sb2d5LXByZXNlbmNlLWluLWNoaW5hLTMwMDk4MDQ0MS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Better Buy: Amgen vs. Johnson & Johnson", "desc": null, "date": "23/04/2020", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzA0LzIzL2JldHRlci1idXktYW1nZW4tdnMtam9obnNvbi1qb2huc29uLmFzcHjSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZRME0xV1hrd2J6UlZjbFZKVFJDM0FSaVRBaWdCTWdZRlFwQUpKUWc=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Keith Speights", "sentiment": "negative"}, {"title": "Michael Lange named Norgine's German general manager", "desc": null, "date": "20/01/2020", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9taWNoYWVsLWxhbmdlLW5hbWVkLW5vcmdpbmUtcy1nZXJtYW4tZ2VuZXJhbC1tYW5hZ2Vy0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWFOV1UzVm5adFpXMUZlVGhGVFJDM0FSaVRBaWdCTWdhcGRZck5zUVU=-w200-h112-p-df", "media": "The Pharma Letter", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AbbVie Seeks US and EU Nods for Rinvoq for Psoriatic Arthritis", "desc": null, "date": "02/06/2020", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvYWJidmllLXNlZWtzLXVzLWV1LW5vZHMtMTU0MzAzMDU3Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXFMVXRVUzFWRmNXWjBjMmxQVFJDeUFSaWJBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "1 Stock That Crushed the Market During the Last Recession", "desc": null, "date": "10/04/2020", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzA0LzEwLzEtc3RvY2stdGhhdC1jcnVzaGVkLXRoZS1tYXJrZXQtZHVyaW5nLXRoZS1sYXN0LXJlLmFzcHjSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTRPVGxGVEZWRlNIZENkMFEyVFJDM0FSaVRBaWdCTWdNSmNoSQ=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen And MBC BioLabs Announce Winners Of The Amgen Golden Ticket", "desc": null, "date": "15/09/2020", "link": "news.google.com/articles/CBMieWh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tYW5kLW1iYy1iaW9sYWJzLWFubm91bmNlLXdpbm5lcnMtb2YtdGhlLWFtZ2VuLWdvbGRlbi10aWNrZXQtMzAxMTMwNTc3Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Is Amgen (AMGN) a Good Choice for Dow Membership?", "desc": null, "date": "02/09/2020", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vaXMtYW1nZW4tYW1nbi1hLWdvb2QtY2hvaWNlLWZvci1kb3ctbWVtYmVyc2hpcC01MDc2NTkz0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU5ORmxyUlMxV1dVZERkbkkxVFJDZUFSaV9BaWdCTWdhQllZanlJQWs=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Alan S. Farley", "sentiment": "negative"}, {"title": "FDA Approves Amgen's RIABNI\u2122 (rituximab-arrx), A Biosimilar To Rituxan\u00ae (rituximab)", "desc": null, "date": "17/12/2020", "link": "news.google.com/articles/CBMigwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2ZkYS1hcHByb3Zlcy1hbWdlbnMtcmlhYm5pLXJpdHV4aW1hYi1hcnJ4LWEtYmlvc2ltaWxhci10by1yaXR1eGFuLXJpdHV4aW1hYi0zMDExOTU0OTIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Joins Dow Jones Industrial Average as the Benchmark Index Revamps to 'Better Reflect' the U.S. Economy", "desc": null, "date": "31/08/2020", "link": "news.google.com/articles/CBMieWh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvYW1nZW4tam9pbnMtZG93LWpvbmVzLWluZHVzdHJpYWwtYXZlcmFnZS1hcy10aGUtYmVuY2htYXJrLWluZGV4LXJldmFtcHMtdG8tYmV0dGVyLXJlZmxlY3TSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTBlRmxSZW1GYWFWZFdkRm8wVFJEckFSaldBU2dCTWdhaEpJNnRHUWc=-w200-h112-p-df", "media": "Nasdaq", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Stock Up 50% But Revenues Grew Just 3%", "desc": null, "date": "14/08/2020", "link": "news.google.com/articles/CBMiZ2h0dHBzOi8vd3d3LnRyZWZpcy5jb20vc3RvY2svYW1nbi9hcnRpY2xlcy80OTYyMzcvYW1nZW4tc3RvY2stdXAtNTAtYnV0LXJldmVudWVzLWdyZXctanVzdC0zLzIwMjAtMDgtMTTSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNUZOMUJ5T0hSSU0yNU1VekJCVFJDYkFSakdBaWdCTWdzSkE0cG9yaVU5RUtuVXdB=-w200-h112-p-df", "media": "Trefis", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Is Amgen Stock A Buy As The Biotech Company Deepens Its Cancer Focus?", "desc": null, "date": "28/12/2020", "link": "news.google.com/articles/CBMiPmh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2FtZ2VuLXN0b2NrLWJ1eS1ub3cv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNDNUME55TFcxblFuRTFNa1pvVFJDb0FSaXJBaWdCTWdzSkVZemtTcVFyanpuUjBB=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "Salesforce, Amgen and Honeywell added to Dow in major shake-up to the average", "desc": null, "date": "24/08/2020", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjAvMDgvMjQvc2FsZXNmb3JjZS1hbWdlbi1hbmQtaG9uZXl3ZWxsLWFkZGVkLXRvLWRvdy1pbi1tYWpvci1zaGFrZXVwLXRvLXRoZS1hdmVyYWdlLmh0bWzSAXRodHRwczovL3d3dy5jbmJjLmNvbS9hbXAvMjAyMC8wOC8yNC9zYWxlc2ZvcmNlLWFtZ2VuLWFuZC1ob25leXdlbGwtYWRkZWQtdG8tZG93LWluLW1ham9yLXNoYWtldXAtdG8tdGhlLWF2ZXJhZ2UuaHRtbA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWhUREl4YmpOa2RtWTJWRlUyVFJDb0FSaXNBaWdCTWdhVlFaYklxQWc=-w200-h112-p-df", "media": "CNBC", "site": null, "reporter": "Pippa Stevens", "sentiment": "positive"}, {"title": "Cherry Picking Is Tempting", "desc": null, "date": "03/11/2020", "link": "news.google.com/articles/CBMiR2h0dHBzOi8vd3d3LmZhLW1hZy5jb20vbmV3cy9jaGVycnktcGlja2luZy1pcy10ZW1wdGluZy01ODgwMS5odG1sP3ByaW500gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNHRaRjkyT0ZGalFYZGhNMUpuVFJDcEFSaXFBaWdCTWdB=-w200-h112-p-df", "media": "FA Mag", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen Presents First Clinical Data for AMG 757 at SITC 2020", "desc": null, "date": "09/11/2020", "link": "news.google.com/articles/CBMic2h0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tcHJlc2VudHMtZmlyc3QtY2xpbmljYWwtZGF0YS1mb3ItYW1nLTc1Ny1hdC1zaXRjLTIwMjAtMzAxMTY4MzEyLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Way forward unclear for Cytokinetics and Amgen", "desc": null, "date": "16/11/2020", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS93YXktZm9yd2FyZC11bmNsZWFyLWZvci1jeXRva2luZXRpY3MtYW5kLWFtZ2Vu0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdkbE55UVZSYU4wbEdkbkV4VFJDM0FSaVRBaWdCTWdZaHBKQ01OUVU=-w200-h112-p-df", "media": "The Pharma Letter", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "IPO Launch: Checkmate Pharmaceuticals Proposes $75 Million IPO - IPOs On TheStreet - U.S. IPO Research & Opinion", "desc": null, "date": "04/08/2020", "link": "news.google.com/articles/CBMiR2h0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vaXBvL25ld3MvY2hlY2ttYXRlLXBoYXJtYWNldXRpY2Fscy1pcG8tbGF1bmNo0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVJkbXg2Ym5SMGRpMWpXVk42VFJDb0FSaXNBaWdCTWdZQjBJS0dTQUk=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Donovan Jones", "sentiment": "negative"}, {"title": "GSK to widen COVID-19 antibody treatment trial after safety clearance", "desc": null, "date": "06/10/2020", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvZ3NrLXdpZGVuLWNvdmlkLTE5LWFudGlib2R5LTEyMDc1NjM5Ny5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHpSa1pvYUdWVWRrTlFkRkYzVFJDekFSaWFBaWdCTWdZQmhaYkVzUWM=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "IPO Preview: Pandion Therapeutics Starts $75 Million IPO Effort - IPOs On TheStreet - U.S. IPO Research & Opinion", "desc": null, "date": "03/07/2020", "link": "news.google.com/articles/CBMiO2h0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vaXBvL25ld3MvcGFuZGlvbi10aGVyYXBldXRpY3MtaXBv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDJiVjgxTnkxUFFqRmFaMnR0VFJDb0FSaXNBaWdCTWdhTm9JeUlPQVU=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Donovan Jones", "sentiment": "negative"}, {"title": "Amgen Licenses AMG 634, An Investigational Treatment For Tuberculosis And Leprosy, To Medicines Development for ...", "desc": null, "date": "22/12/2020", "link": "news.google.com/articles/CBMiswFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLWxpY2Vuc2VzLWFtZy02MzQtYW4taW52ZXN0aWdhdGlvbmFsLXRyZWF0bWVudC1mb3ItdHViZXJjdWxvc2lzLWFuZC1sZXByb3N5LXRvLW1lZGljaW5lcy1kZXZlbG9wbWVudC1mb3ItZ2xvYmFsLWhlYWx0aC0zMDExOTc4MDIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "IPO Launch: Oncorus Targets $87 Million U.S. IPO - IPOs On TheStreet - U.S. IPO Research & Opinion", "desc": null, "date": "28/09/2020", "link": "news.google.com/articles/CBMiNWh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vaXBvL25ld3Mvb25jb3J1cy1pcG8tbGF1bmNo0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTFiRnB3T1RSYWVtRlZORGx1VFJDb0FSaXNBaWdCTWdNSnNCQQ=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Donovan Jones", "sentiment": "negative"}, {"title": "Amgen to Acquire Rodeo Therapeutics Corporation", "desc": null, "date": "30/03/2021", "link": "news.google.com/articles/CBMiZ2h0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tdG8tYWNxdWlyZS1yb2Rlby10aGVyYXBldXRpY3MtY29ycG9yYXRpb24tMzAxMjU4OTU3Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDFZbFp5VUhWVFNXTTFaMWx0VFJDZEFSakFBaWdCTWdrQllJSWpKMms5OWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen completes $1.9B acquisition of Five Prime Therapeutics", "desc": null, "date": "16/04/2021", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3LmRydWdkZWxpdmVyeWJ1c2luZXNzLmNvbS9hbWdlbi1jb21wbGV0ZXMtMS05Yi1hY3F1aXNpdGlvbi1vZi1maXZlLXByaW1lLXRoZXJhcGV1dGljcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNUNXR05zY1VSTlRHcEhZV1Z6VFJDMUFSaVhBaWdCTWdPVlVnWQ=-w200-h112-p-df", "media": "Drug Delivery Business News", "site": null, "reporter": "Sean Whooley", "sentiment": "negative"}, {"title": "Amgen Stock Gives Every Indication Of Being Fairly Valued", "desc": null, "date": "31/03/2021", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1zdG9jay1naXZlcy1ldmVyeS1pbmRpY2F0aW9uLTAzMTI0MzQ5Ni5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNW1hbEZDWjFWUVgxZG9UbTVYVFJDdUFSaWlBaWdCTWdPQkJBbw=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "In quest to interrupt aging, East Bay biotech lands drug, equity deal with Amgen - San Francisco Business Times", "desc": null, "date": "14/04/2021", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDIxLzA0LzE0L2FnaW5nLWFtZ2VuLWFtZ24tYmlvYWdlLWxhYnMuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTRWV2hOYlU5bVJITkhhbVpsVFJDb0FSaXNBaWdCTWdZdEpvak5HUW8=-w200-h112-p-df", "media": "San Francisco Business Times ", "site": null, "reporter": "Ron Leuty", "sentiment": "negative"}, {"title": "Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash USA - English - USA - English", "desc": null, "date": "04/03/2021", "link": "news.google.com/articles/CBMieGh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tdG8tYWNxdWlyZS1maXZlLXByaW1lLXRoZXJhcGV1dGljcy1mb3ItMS05LWJpbGxpb24taW4tY2FzaC0zMDEyNDAzNTguaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen to Acquire Five Prime for $1.9B, Adding Phase III Gastric Cancer Candidate", "desc": null, "date": "04/03/2021", "link": "news.google.com/articles/CBMib2h0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL25ld3MvYW1nZW4tdG8tYWNxdWlyZS1maXZlLXByaW1lLWZvci0xLTliLWFkZGluZy1waGFzZS1paWktZ2FzdHJpYy1jYW5jZXItY2FuZGlkYXRlL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNW5iM1JtU1ZOVk5WbEVZVnB3VFJDM0FSaVRBaWdCTWdrQmtvcGxQcVhnelFF=-w200-h112-p-df", "media": "Genetic Engineering & Biotechnology News", "site": null, "reporter": "Alex Philippidis", "sentiment": "negative"}, {"title": "Amgen Stock Gives Every Indication Of Being Fairly Valued", "desc": null, "date": "04/06/2021", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1zdG9jay1naXZlcy1ldmVyeS1pbmRpY2F0aW9uLTAyMDc0Mjk1My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNDJSRkJXYzBNMU9IUkplVzFqVFJDdUFSaWlBaWdCTWdNQkJBZw=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "EXCLUSIVE: Sree Batchu On The Power Of The Los Angeles MedTech Ecosystem, Why You Should Care - Amgen (NA", "desc": null, "date": "11/05/2021", "link": "news.google.com/articles/CBMiiAFodHRwczovL3d3dy5iZW56aW5nYS5jb20vbmV3cy8yMS8wNS8yMTAxMzYzMS9leGNsdXNpdmUtc3JlZS1iYXRjaHUtb24tdGhlLXBvd2VyLW9mLXRoZS1sb3MtYW5nZWxlcy1tZWR0ZWNoLWVjb3N5c3RlbS13aHkteW91LXNob3VsZC1jYXJl0gEtaHR0cHM6Ly93d3cuYmVuemluZ2EuY29tL2FtcC9jb250ZW50LzIxMDEzNjMx?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXlOM2hZVXkxRlZWcHlUaTFWVFJDM0FSaVRBaWdCTWdhZFI1cEtvZ2s=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Renato Capelj", "sentiment": "negative"}, {"title": "ARWR: Multiple Data Readouts in 2021\u2026", "desc": null, "date": "09/02/2021", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vc2NyLnphY2tzLmNvbS9uZXdzL25ld3MtZGV0YWlscy8yMDIxL0FSV1ItTXVsdGlwbGUtRGF0YS1SZWFkb3V0cy1pbi0yMDIxL2RlZmF1bHQuYXNweNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNWljbkJaZDJwcWRGRlNRazlvVFJETUFSajNBU2dCTWdtQkE0S0xtYWlLMGdB=-w200-h112-p-df", "media": "Zacks Small Cap Research", "site": null, "reporter": "David Bautz", "sentiment": "negative"}, {"title": "How to Trade the FDA Approval Game", "desc": null, "date": "11/05/2021", "link": "news.google.com/articles/CBMiRGh0dHBzOi8vd3d3LmVuZXJneWFuZGNhcGl0YWwuY29tL2hvdy10by10cmFkZS10aGUtZmRhLWFwcHJvdmFsLWdhbWUv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXpNeTFVYTJGaFUxOTVjRFJXVFJDckFSaW5BaWdCTWdZTlFKenBuQWs=-w200-h112-p-df", "media": "Energy & Capital", "site": null, "reporter": "Christian DeHaemer", "sentiment": "negative"}, {"title": "Sanofi (SNY) Gets Label Expansion Nod for Sarclisa in Europe", "desc": null, "date": "19/04/2021", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vbnoubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL3Nhbm9maS1zbnktZ2V0cy1sYWJlbC1leHBhbnNpb24tMTMyNTAxNjkxLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXJlWE5ETlhaTVpsSnpkMnN6VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo New Zealand News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Releases 8th Edition of Biosimilar Trends Report", "desc": null, "date": "22/09/2021", "link": "news.google.com/articles/CBMibmh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tcmVsZWFzZXMtOHRoLWVkaXRpb24tb2YtYmlvc2ltaWxhci10cmVuZHMtcmVwb3J0LTMwMTM4MjE3My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTBTemxPZWtObmNHMW1PVXAwVFJEX0FSakZBU2dCTWdNSkJBdw=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for ...", "desc": null, "date": "07/10/2021", "link": "news.google.com/articles/CBMitQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLWFuZC1uZXVtb3JhLXRoZXJhcGV1dGljcy1hbm5vdW5jZS1zdHJhdGVnaWMtcmQtY29sbGFib3JhdGlvbi10by1hY2NlbGVyYXRlLW5vdmVsLXByZWNpc2lvbi10aGVyYXBpZXMtZm9yLWJyYWluLWRpc2Vhc2VzLTMwMTM5NDc3MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "How big is the mid-2020's LOE problem for Amgen?", "desc": null, "date": "17/08/2021", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9ob3ctYmlnLWlzLXRoZS1taWQtMjAyMC1zLWxvZS1wcm9ibGVtLWZvci1hbWdlbtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUJVamt3U3pGSFJWWjVPWGx1VFJDM0FSaVRBaWdCTWdZQmdJcXl4QVE=-w200-h112-p-df", "media": "The Pharma Letter", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "JNJ: 4 Top Healthcare Stocks on the Dow Jones Index", "desc": null, "date": "10/08/2021", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2puai11bmgtbXJrLWFtZ24tNC10b3AtaGVhbHRoY2FyZS1zdG9ja3Mtb24tdGhlLWRvdy1qb25lcy1pbmRleC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXlkWGxwY1Y4eFJGcExlVlZ4VFJEaEFSamhBU2dCTWdhbFU0ak91UVk=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Pragya Pandey", "sentiment": "positive"}, {"title": "Amgen To Acquire Privately Held Teneobio For $900 Million In Cash With Future Contingent Milestone Payments", "desc": null, "date": "27/07/2021", "link": "news.google.com/articles/CBMiogFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLXRvLWFjcXVpcmUtcHJpdmF0ZWx5LWhlbGQtdGVuZW9iaW8tZm9yLTkwMC1taWxsaW9uLWluLWNhc2gtd2l0aC1mdXR1cmUtY29udGluZ2VudC1taWxlc3RvbmUtcGF5bWVudHMtMzAxMzQyNTY1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTZXRFZSUTA5aVJUbEplVTlRVFJDakFSaTFBaWdCTWdNQndCQQ=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "This Could Be the Next Biogen", "desc": null, "date": "27/09/2021", "link": "news.google.com/articles/CBMiO2h0dHBzOi8vcHJvLnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL2dpbmtvLWJpb3dvcmtzLTE1NzgwOTI40gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNHRRemhXUW5kNFdrUnZlblZmVFJEaEFSamhBU2dCTWdPQmdRZw=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Timothy Collins", "sentiment": "positive"}, {"title": "7 Dividend Growth Stocks For September 2021 - Dividend Strategists", "desc": null, "date": "02/09/2021", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vZGl2aWRlbmRzdHJhdGVnaXN0cy9kaXZpZGVuZC1pZGVhcy83LWRpdmlkZW5kLWdyb3d0aC1zdG9ja3MtZm9yLXNlcHRlbWJlci0yMDIx0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNWhlRmR2V1UxbWQza3RYMDloVFJEaEFSamhBU2dCTWdrQm9Zb0x1YWRGOUFB=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Ferdi Scheepers", "sentiment": "negative"}, {"title": "GLOBAL BIOTECHNOLOGY LEADER AMGEN BREAKS GROUND ON NEW MANUFACTURING FACILITY IN NORTH ...", "desc": null, "date": "07/03/2022", "link": "news.google.com/articles/CBMilwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2dsb2JhbC1iaW90ZWNobm9sb2d5LWxlYWRlci1hbWdlbi1icmVha3MtZ3JvdW5kLW9uLW5ldy1tYW51ZmFjdHVyaW5nLWZhY2lsaXR5LWluLW5vcnRoLWNhcm9saW5hLTMwMTQ5NjkxMi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMGEN AND GENERATE BIOMEDICINES ANNOUNCE MULTI-TARGET, MULTI-MODALITY RESEARCH ...", "desc": null, "date": "06/01/2022", "link": "news.google.com/articles/CBMinQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLWFuZC1nZW5lcmF0ZS1iaW9tZWRpY2luZXMtYW5ub3VuY2UtbXVsdGktdGFyZ2V0LW11bHRpLW1vZGFsaXR5LXJlc2VhcmNoLWNvbGxhYm9yYXRpb24tYWdyZWVtZW50LTMwMTQ1NTE1Ny5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Olpasiran Lowers Lipoprotein Levels in Phase II", "desc": null, "date": "01/06/2022", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLW9scGFzaXJhbi1sb3dlcnMtbGlwb3Byb3RlaW4tMTI0NzEyMTU3Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXBSalZOTFhwb2FsbEJSMlI0VFJDeUFSaWJBaWdCTWdZQmtJeFB0UVU=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Outlines Growth Strategy Through 2030", "desc": null, "date": "08/02/2022", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3LnN0cmVldGluc2lkZXIuY29tL0NvcnBvcmF0ZStOZXdzL0FtZ2VuKyUyOEFNR04lMjkrT3V0bGluZXMrR3Jvd3RoK1N0cmF0ZWd5K1Rocm91Z2grMjAzMC8xOTU3Mzg2MS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXlWbGRDUTJacGRFNVNTR2MwVFJESUFSaklBU2dCTWdNSnNCUQ=-w200-h112-p-df", "media": "StreetInsider.com", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMGEN PROVIDES LONG-TERM GUIDANCE THROUGH 2030 DURING BUSINESS REVIEW MEETING", "desc": null, "date": "08/02/2022", "link": "news.google.com/articles/CBMigwFodHRwczovL3d3dy5hbWdlbi5jb20vbmV3c3Jvb20vcHJlc3MtcmVsZWFzZXMvMjAyMi8wMi9hbWdlbi1wcm92aWRlcy1sb25nLXRlcm0tZ3VpZGFuY2UtdGhyb3VnaC0yMDMwLWR1cmluZy1idXNpbmVzcy1yZXZpZXctbWVldGluZ9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNW1TM2xYZEU5eGFTMXVjamQzVFJEMkFSak5BU2dCTWdPVkF3dw=-w200-h112-p-df", "media": "Amgen", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen to buy back $6 bln in shares this qtr, provides long-term profit forecast", "desc": null, "date": "08/02/2022", "link": "news.google.com/articles/CBMiiQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9hbWdlbi1wbGFucy02LWJsbi1zaGFyZS1idXliYWNrLXExLXNlZXMtZWFybmluZ3MtZG91YmxpbmctYnktMjAzMC0yMDIyLTAyLTA4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXJVbWh0WTNSNlNUazRUR1JaVFJDM0FSaVRBaWdCTWdhUmNaVHhMQWM=-w200-h112-p-df", "media": "Reuters", "site": null, "reporter": "Leroy Leo & Deena Beasley", "sentiment": "negative"}, {"title": "Global biotech breaks ground on 355-job Holly Springs facility. Here's when hiring will ramp up. - Triangle Business ...", "desc": null, "date": "07/03/2022", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS90cmlhbmdsZS9uZXdzLzIwMjIvMDMvMDcvYW1nZW4tYnJlYWtzLWdyb3VuZC1vbi1ob2xseS1zcHJpbmdzLXNpdGUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXJjV2hwZEVFd2RtOHlVbVpXVFJDb0FSaXNBaWdCTWdNQmdBUQ=-w200-h112-p-df", "media": "Triangle Business Journal ", "site": null, "reporter": "Zac Ezzone", "sentiment": "negative"}, {"title": "AMGEN ANNOUNCES POSITIVE TOP-LINE RESULTS FROM PHASE 3 STUDY OF ABP 654, BIOSIMILAR ...", "desc": null, "date": "18/04/2022", "link": "news.google.com/articles/CBMiqwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLWFubm91bmNlcy1wb3NpdGl2ZS10b3AtbGluZS1yZXN1bHRzLWZyb20tcGhhc2UtMy1zdHVkeS1vZi1hYnAtNjU0LWJpb3NpbWlsYXItY2FuZGlkYXRlLXRvLXN0ZWxhcmEtdXN0ZWtpbnVtYWItMzAxNTI3MzMzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug ...", "desc": null, "date": "20/01/2022", "link": "news.google.com/articles/CBMi0AFodHRwczovL21hcmtldHMuYnVzaW5lc3NpbnNpZGVyLmNvbS9uZXdzL3N0b2Nrcy90aGUtZGFpbHktYmlvdGVjaC1wdWxzZS1ub3ZhdmF4LWNvdmlkLXNob3QtYXV0aG9yaXplZC1pbi1hdXN0cmFsaWEtenltZXdvcmtzLXJlc3RydWN0dXJlcy1vcnBoYW4tZHJ1Zy1kZXNpZ25hdGlvbi1mb3ItbWFya2VyLXMtcGFuY3JlYXRpYy1jYW5jZXItZHJ1Zy0xMDMxMTE2MDAw0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXlVVmh4YTA1T2IycHRiMkpzVFJEQ0FSaURBaWdCTWdrRlk0ekVKdWxqTXdF=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen says IRS seeks billions in back taxes, shares fall 6%", "desc": null, "date": "27/04/2022", "link": "news.google.com/articles/CBMiemh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2hlYWx0aGNhcmUtcGhhcm1hY2V1dGljYWxzL2FtZ2VuLXNheXMtaXJzLXNlZWtzLWFub3RoZXItNTEtYmlsbGlvbi1iYWNrLXRheGVzLTIwMjItMDQtMjcv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTFSMGxTZEZCU2JYUXpNM0o2VFJDM0FSaVRBaWdCTWdrTklKWkdHcW84NndF=-w200-h112-p-df", "media": "Reuters", "site": null, "reporter": "Deena Beasley", "sentiment": "negative"}, {"title": "Top 7 Dividend Growth Stock Picks for 2022 - Dividend Strategists", "desc": null, "date": "03/01/2022", "link": "news.google.com/articles/CBMiZ2h0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vZGl2aWRlbmRzdHJhdGVnaXN0cy9kaXZpZGVuZC1pZGVhcy90b3AtNy1kaXZpZGVuZC1ncm93dGgtc3RvY2stcGlja3MtZm9yLTIwMjLSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDBObnB5UlY5b1ZIVkdOVXB6VFJEQ0FSaURBaWdCTWdhTkVaVG9xUWM=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Ferdi Scheepers", "sentiment": "positive"}, {"title": "AMGEN AND ARRAKIS THERAPEUTICS ANNOUNCE MULTI-TARGET COLLABORATION TO IDENTIFY NOVEL RNA ...", "desc": null, "date": "11/01/2022", "link": "news.google.com/articles/CBMitQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLWFuZC1hcnJha2lzLXRoZXJhcGV1dGljcy1hbm5vdW5jZS1tdWx0aS10YXJnZXQtY29sbGFib3JhdGlvbi10by1pZGVudGlmeS1ub3ZlbC1ybmEtZGVncmFkZXItc21hbGwtbW9sZWN1bGUtdGhlcmFwZXV0aWNzLTMwMTQ1ODM4MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iKkNnNUxWV2hQVTAxVWQxUldSSFp2VFJCd0dNY0JLQUV5QnAyamxJdTVCZw=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Should You Invest in the VanEck Biotech ETF (BBH)?", "desc": null, "date": "10/01/2022", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vYXUubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2ludmVzdC12YW5lY2stYmlvdGVjaC1ldGYtYmJoLTExMjAxMTA4My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNW9YMEpFWm1Wd1ZqVjVha2s0VFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo News Australia", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "NEW DATA SHOWCASES HOW AMGEN IS ADVANCING ALL ANGLES OF CANCER CARE THROUGH INNOVATIVE ...", "desc": null, "date": "26/05/2022", "link": "news.google.com/articles/CBMiuwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL25ldy1kYXRhLXNob3djYXNlcy1ob3ctYW1nZW4taXMtYWR2YW5jaW5nLWFsbC1hbmdsZXMtb2YtY2FuY2VyLWNhcmUtdGhyb3VnaC1pbm5vdmF0aXZlLW9uY29sb2d5LXBvcnRmb2xpby1hbmQtcGlwZWxpbmUtYXQtYXNjby0yMDIyLTMwMTU1NjI5Mi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "FDA APPROVES RIABNI\u2122 (RITUXIMAB-ARRX), A BIOSIMILAR TO RITUXAN\u00ae (RITUXIMAB), FOR ADULTS WITH ...", "desc": null, "date": "06/06/2022", "link": "news.google.com/articles/CBMitAFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2ZkYS1hcHByb3Zlcy1yaWFibmktcml0dXhpbWFiLWFycngtYS1iaW9zaW1pbGFyLXRvLXJpdHV4YW4tcml0dXhpbWFiLWZvci1hZHVsdHMtd2l0aC1tb2RlcmF0ZS10by1zZXZlcmUtcmhldW1hdG9pZC1hcnRocml0aXMtMzAxNTYxNTU2Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "EUROPEAN COMMISSION APPROVES LUMYKRAS\u00ae (SOTORASIB) FOR PATIENTS WITH KRAS G12C-MUTATED ...", "desc": null, "date": "10/01/2022", "link": "news.google.com/articles/CBMirwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2V1cm9wZWFuLWNvbW1pc3Npb24tYXBwcm92ZXMtbHVteWtyYXMtc290b3Jhc2liLWZvci1wYXRpZW50cy13aXRoLWtyYXMtZzEyYy1tdXRhdGVkLWFkdmFuY2VkLW5vbi1zbWFsbC1jZWxsLWx1bmctY2FuY2VyLTMwMTQ1Njg2OS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "LUMAKRAS\u00ae (SOTORASIB) RECEIVES APPROVAL IN JAPAN FOR PATIENTS WITH KRAS G12C-MUTATED ...", "desc": null, "date": "20/01/2022", "link": "news.google.com/articles/CBMirQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2x1bWFrcmFzLXNvdG9yYXNpYi1yZWNlaXZlcy1hcHByb3ZhbC1pbi1qYXBhbi1mb3ItcGF0aWVudHMtd2l0aC1rcmFzLWcxMmMtbXV0YXRlZC1hZHZhbmNlZC1ub24tc21hbGwtY2VsbC1sdW5nLWNhbmNlci0zMDE0NjQ2OTcuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "NEW DATA FURTHER REINFORCE EFFICACY OF TEZSPIRE\u2122 (TEZEPELUMAB-EKKO) IN A BROAD POPULATION ...", "desc": null, "date": "26/02/2022", "link": "news.google.com/articles/CBMiqAFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL25ldy1kYXRhLWZ1cnRoZXItcmVpbmZvcmNlLWVmZmljYWN5LW9mLXRlenNwaXJlLXRlemVwZWx1bWFiLWVra28taW4tYS1icm9hZC1wb3B1bGF0aW9uLW9mLXNldmVyZS1hc3RobWEtcGF0aWVudHMtMzAxNDkwODIzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS", "desc": null, "date": "07/02/2022", "link": "news.google.com/articles/CBMieWh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tcmVwb3J0cy1mb3VydGgtcXVhcnRlci1hbmQtZnVsbC15ZWFyLTIwMjEtZmluYW5jaWFsLXJlc3VsdHMtMzAxNDc2ODY3Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVFiSGxSWTBvM05uQm1aVlZKVFJDaUFSaTJBaWdCTWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "7 Dividend Growth Stocks For January 2022 - Dividend Strategists", "desc": null, "date": "18/01/2022", "link": "news.google.com/articles/CBMiZmh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vZGl2aWRlbmRzdHJhdGVnaXN0cy9kaXZpZGVuZC1pZGVhcy83LWRpdmlkZW5kLWdyb3d0aC1zdG9ja3MtZm9yLWphbnVhcnktMjAyMtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHdlVGR3U1c1c1ZUZzFlWGg0VFJEQ0FSaURBaWdCTWdZNUlJbzZEQXM=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Ferdi Scheepers", "sentiment": "negative"}, {"title": "Lupin deal with Axantia on biosimilar pegfilgrastim", "desc": null, "date": "01/02/2022", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9sdXBpbi1kZWFsLXdpdGgtYXhhbnRpYS1vbi1iaW9zaW1pbGFyLXBlZ2ZpbGdyYXN0aW3SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNHpRVkYzVm01amMwaFVRMGhVVFJDLUFSaUtBaWdCTWdNQm9CQQ=-w200-h112-p-df", "media": "The Pharma Letter", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "7 Dividend Growth Stocks For April 2022 - Dividend Strategists", "desc": null, "date": "12/04/2022", "link": "news.google.com/articles/CBMiYGh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vZGl2aWRlbmRzdHJhdGVnaXN0cy9kaXZpZGVuZC1pZGVhcy83LWRpdmlkZW5kLWdyb3d0aC1zdG9ja3MtYXByaWwtMjAyMtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHhiRTlyVFRGeFFVSklUWFJyVFJEaEFSamhBU2dCTWdhQnNvd0NTd1U=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Ferdi Scheepers", "sentiment": "negative"}, {"title": "Dow Brushes Off Rising Bond Yields With Triple-Digit Win", "desc": null, "date": "08/02/2022", "link": "news.google.com/articles/CBMidWh0dHBzOi8vd3d3LnNjaGFlZmZlcnNyZXNlYXJjaC5jb20vY29udGVudC9lemluZXMvMjAyMi8wMi8wOC9kb3ctYnJ1c2hlcy1vZmYtcmlzaW5nLWJvbmQteWllbGRzLXdpdGgtdHJpcGxlLWRpZ2l0LXdpbtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNHpVMlJqTTBzNVoxQTNWVkZNVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Schaeffers Research", "site": null, "reporter": "Fernanda Horner", "sentiment": "negative"}, {"title": "XXII: Is 22nd Century Group a Buy After the FDA Grants Approval to Market its VLN Cigarettes", "desc": null, "date": "05/01/2022", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL3h4aWktdnJ0eC1hbWduLXNiaG15LWlzLTIybmQtY2VudHVyeS1ncm91cC1hLWJ1eS1hZnRlci10aGUtZmRhLWdyYW50cy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVVSV1pXVEdSUVFXaHRiazUzVFJDM0FSaVRBaWdCTWdZRllwQUdNUWM=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Aditi Ganguly", "sentiment": "negative"}, {"title": "5 Dow Stocks Outperforming the S&P 500 Year to Date", "desc": null, "date": "16/06/2022", "link": "news.google.com/articles/CBMiSGh0dHBzOi8vc3RvY2t4cG8uY29tLzUtZG93LXN0b2Nrcy1vdXRwZXJmb3JtaW5nLXRoZS1zcC01MDAteWVhci10by1kYXRlL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHlXblkxV0VjemR6Uk5VM000VFJETEFSajRBU2dCTWdZVkFJclNyQVU=-w200-h112-p-df", "media": "Stockxpo", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMGEN OPENS NEW STATE-OF-THE-ART RESEARCH AND DEVELOPMENT LABORATORY SITE IN SAN ...", "desc": null, "date": "06/10/2022", "link": "news.google.com/articles/CBMimwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLW9wZW5zLW5ldy1zdGF0ZS1vZi10aGUtYXJ0LXJlc2VhcmNoLWFuZC1kZXZlbG9wbWVudC1sYWJvcmF0b3J5LXNpdGUtaW4tc2FuLWZyYW5jaXNjby1iYXktYXJlYS0zMDE2NDE4MTIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVFiSGxSWTBvM05uQm1aVlZKVFJDaUFSaTJBaWdCTWdhZG81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMGN: Amgen is Our Growth Stock of the Week\u2026", "desc": null, "date": "12/10/2022", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2FtZ24tYW1nZW4taXMtb3VyLWdyb3d0aC1zdG9jay1vZi10aGUtd2Vlay01NzY5MDIyMC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUhaM2xtVGtsb01qaDFaaTF4VFJDakFSaTJBaWdCTWdZMUlJVHp3QU0=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Jaimini Desai", "sentiment": "positive"}, {"title": "What's Driving Growth For Amgen Stock?", "desc": null, "date": "14/12/2022", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMi8xMi8xNC93aGF0cy1kcml2aW5nLWdyb3d0aC1mb3ItYW1nZW4tc3RvY2sv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVVWbE5OYVZsRFUwc3pTbkpRVFJDM0FSaVRBaWdCTWdhaG81S011UVk=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Dips More Than Broader Markets: What You Should Know", "desc": null, "date": "27/09/2022", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLWRpcHMtbW9yZS1icm9hZGVyLTIxNTAwOTExMy5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVljblZMWkRkblRYQjFka3hMVFJDM0FSaVRBaWdCTWdZTlFaTFVMQWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Gets $28.5B Bridge Loan to Fund Horizon Therapeutics (HZNP) Deal", "desc": null, "date": "12/12/2022", "link": "news.google.com/articles/CBMif2h0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIyLTEyLTEyL2FtZ2VuLWFtZ24tc2VjdXJlcy1icmlkZ2UtbG9hbi10by1mdW5kLWhvcml6b24tdGhlcmFwZXV0aWNzLWh6bnAtYWNxdWlzaXRpb27SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUhYekpITjFFM2IzcDJUbU5EVFJDb0FSaXNBaWdCTWdhWjhvWkxVUU0=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Josyana Joshua", "sentiment": "negative"}, {"title": "AMGEN PRESENTS NEW TARLATAMAB CLINICAL DATA AT WCLC 2022", "desc": null, "date": "08/08/2022", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tcHJlc2VudHMtbmV3LXRhcmxhdGFtYWItY2xpbmljYWwtZGF0YS1hdC13Y2xjLTIwMjItMzAxNjAxNzY3Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen dives deeper into rare disease drugs with $27.8 bln Horizon deal", "desc": null, "date": "12/12/2022", "link": "news.google.com/articles/CBMidGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL21hcmtldHMvZGVhbHMvYW1nZW4tc2V0LWJ1eS1iaW90ZWNoLWZpcm0taG9yaXpvbi0yNi1ibG4tdmFsdWF0aW9uLWJsb29tYmVyZy1uZXdzLTIwMjItMTItMTIv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXdSR3RWTkU1UFpFdDBPVWx0VFJDM0FSaVRBaWdCTWdhWmNaVHhMQWM=-w200-h112-p-df", "media": "Reuters", "site": null, "reporter": "Manas Mishra & Bhanvi Satija", "sentiment": "negative"}, {"title": "Amgen to buy Horizon Therapeutics in $26.4 billion deal", "desc": null, "date": "12/12/2022", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjIvMTIvMTIvYW1nZW4tdG8tYnV5LWhvcml6b24tdGhlcmFwZXV0aWNzLWluLTI2cG9pbnQ0LWJpbGxpb24tZGVhbC5odG1s0gFjaHR0cHM6Ly93d3cuY25iYy5jb20vYW1wLzIwMjIvMTIvMTIvYW1nZW4tdG8tYnV5LWhvcml6b24tdGhlcmFwZXV0aWNzLWluLTI2cG9pbnQ0LWJpbGxpb24tZGVhbC5odG1s?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTNiVEZtTXpFMGR6ZFhRWFkwVFJDb0FSaXNBaWdCTWdZTk1JNUZuZ2s=-w200-h112-p-df", "media": "CNBC", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "How This Obesity Underdog Is Creeping Up On Novo, Lilly", "desc": null, "date": "01/12/2022", "link": "news.google.com/articles/CBMibWh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2FtZ2VuLXN0b2NrLWhvdy1pdHMtb2Jlc2l0eS10cmVhdG1lbnQtaXMtY3JlZXBpbmctdXAtb24tbm92by1saWxseS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTFUR1EyTmpsUE0zVlJNbkExVFJDb0FSaXNBaWdCTWdhQmNaTFZwQWM=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "Is Amgen Stock a Buy Now?", "desc": null, "date": "20/10/2022", "link": "news.google.com/articles/CBMiQ2h0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIyLzEwLzIwL2lzLWFtZ2VuLXN0b2NrLWEtYnV5LW5vdy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXljeTFsVmpkSllYbE9OVXhZVFJDM0FSaVRBaWdCTWdhSllaUWxLUWs=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "David Jagielski", "sentiment": "negative"}, {"title": "Amgen (NASDAQ:AMGN) shareholders have earned a 7.3% CAGR over the last five years", "desc": null, "date": "23/09/2022", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvYW1nZW4tbmFzZGFxLWFtZ24tc2hhcmVob2xkZXJzLWVhcm5lZC0xMjAxMDkwMzYuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdkakZCVjBobVZuUmFhbFkyVFJDSEFSajJBaWdCTWdZQkFvYlZnQXc=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMGEN TO PRESENT NEW RESEARCH ACROSS SERIOUS INFLAMMATORY AND BONE DISEASES AT ACR 2022", "desc": null, "date": "07/11/2022", "link": "news.google.com/articles/CBMijwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLXRvLXByZXNlbnQtbmV3LXJlc2VhcmNoLWFjcm9zcy1zZXJpb3VzLWluZmxhbW1hdG9yeS1hbmQtYm9uZS1kaXNlYXNlcy1hdC1hY3ItMjAyMi0zMDE2Njk4NjcuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVFiSGxSWTBvM05uQm1aVlZKVFJDaUFSaTJBaWdCTWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen says experimental obesity drug has promising durability", "desc": null, "date": "03/12/2022", "link": "news.google.com/articles/CBMihQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9hbWdlbi1zYXlzLWV4cGVyaW1lbnRhbC1vYmVzaXR5LWRydWctaGFzLXByb21pc2luZy1kdXJhYmlsaXR5LTIwMjItMTItMDMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXhWM1I2UkZJMlRtRjBTM1pQVFJDM0FSaVRBaWdCTWdrTklKWkdtcW84Q3dJ=-w200-h112-p-df", "media": "Reuters", "site": null, "reporter": "Deena Beasley", "sentiment": "negative"}, {"title": "HZNP Stock Rockets As Amgen Agrees To Buy Horizon Therapeutics For $27.8 Billion", "desc": null, "date": "12/12/2022", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2h6bnAtc3RvY2stcm9ja2V0cy1hcy1hbWdlbi1hZ3JlZXMtdG8tYnV5LWhvcml6b24tdGhlcmFwZXV0aWNzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNDRaMlpDZEVaTWNIaHFlVzFhVFJDb0FSaXJBaWdCTWdNUlJDQQ=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "AMGEN PRESENTS NEW PHASE 2 DATA THAT SHOW OLPASIRAN DELIVERS SIGNIFICANT REDUCTION IN ...", "desc": null, "date": "06/11/2022", "link": "news.google.com/articles/CBMioQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLXByZXNlbnRzLW5ldy1waGFzZS0yLWRhdGEtdGhhdC1zaG93LW9scGFzaXJhbi1kZWxpdmVycy1zaWduaWZpY2FudC1yZWR1Y3Rpb24taW4tbGlwb3Byb3RlaW5hLWxldmVscy0zMDE2NjkxNDYuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN PRESENTS NEW REPATHA\u00ae (EVOLOCUMAB) DATA AT AHA 2022", "desc": null, "date": "07/11/2022", "link": "news.google.com/articles/CBMibmh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tcHJlc2VudHMtbmV3LXJlcGF0aGEtZXZvbG9jdW1hYi1kYXRhLWF0LWFoYS0yMDIyLTMwMTY3MDU1NS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVRibDlVTW5aaFpYWmljbFJuVFJDc0FSaW1BaWdCTWdhQndZRFR5QVE=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH", "desc": null, "date": "04/08/2022", "link": "news.google.com/articles/CBMia2h0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tdG8tYWNxdWlyZS1jaGVtb2NlbnRyeXgtZm9yLTQtYmlsbGlvbi1pbi1jYXNoLTMwMTU5OTY3Mi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNU5kVFpSYW14aFMwVnROMjVvVFJDdUFSaWlBaWdCTWdrQmNvQWo4V0JVQ3dJ=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Moderna Inc. stock falls Friday, underperforms market", "desc": null, "date": "22/07/2022", "link": "news.google.com/articles/CBMijgFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vZGF0YS1uZXdzL21vZGVybmEtaW5jLXN0b2NrLWZhbGxzLWZyaWRheS11bmRlcnBlcmZvcm1zLW1hcmtldC0wMTY1ODUyMTkxMC02MDQ1ZTA5OGI0M2I_c2l0ZWlkPW1zbmhlYWRsaW5lcyZ0ZXNsYT150gF2aHR0cHM6Ly93d3cubWFya2V0d2F0Y2guY29tL2FtcC9kYXRhLW5ld3MvbW9kZXJuYS1pbmMtc3RvY2stZmFsbHMtZnJpZGF5LXVuZGVycGVyZm9ybXMtbWFya2V0LTAxNjU4NTIxOTEwLTYwNDVlMDk4YjQzYg?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVpZWGxrUkUxVloxVkpNVzlFVFJEaEFSamhBU2dCTWdZQllJeEpzUWM=-w200-h112-p-df", "media": "MarketWatch", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen's short, big move designed to execute at corner of tech and biotech - San Francisco Business Times", "desc": null, "date": "06/10/2022", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDIyLzEwLzA2L2FtZ2VuLWFtZ24tY2FuY2VyLXNvdXRoLXNhbi1mcmFuY2lzY28uaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU9hMWQwV1VGRFZGSk5UR1ZrVFJDb0FSaXNBaWdCTWdZUmdJNkxyUWM=-w200-h112-p-df", "media": "San Francisco Business Times ", "site": null, "reporter": "Ron Leuty", "sentiment": "positive"}, {"title": "Amgen Stock Jumps After Narrowing Race In Obesity Treatment With Novo, Lilly", "desc": null, "date": "08/11/2022", "link": "news.google.com/articles/CBMidmh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2FtZ2VuLXN0b2NrLWp1bXBzLWFmdGVyLW5hcnJvd2luZy1yYWNlLWluLW9iZXNpdHktdHJlYXRtZW50LXdpdGgtbm92by1saWxseS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNWhjalJzWkRKQ1pFSmhWWEpOVFJDb0FSaXNBaWdCTWdtRmNKU1h0Q2JCekFF=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "CCXI Stock Rockets; Amgen Plans $3.7 Billion ChemoCentryx Buyout As Generics Loom", "desc": null, "date": "04/08/2022", "link": "news.google.com/articles/CBMiYmh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2NjeGktc3RvY2stcm9ja2V0cy1hcy1hbWdlbi1wbGFucy1jaGVtb2NlbnRyeXgtdGFrZW92ZXIv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDNVRlJYVVVrdFFrSjBVM2swVFJDb0FSaXNBaWdCTWdrTmdwU0dMaWc5NndF=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "A Congressman Just Sold JPMorgan Stock Ahead Of Earnings: See Two Dividend Stocks He Is Also Trading", "desc": null, "date": "11/10/2022", "link": "news.google.com/articles/CBMingFodHRwczovL21hcmtldHMuYnVzaW5lc3NpbnNpZGVyLmNvbS9uZXdzL3N0b2Nrcy9hLWNvbmdyZXNzbWFuLWp1c3Qtc29sZC1qcG1vcmdhbi1zdG9jay1haGVhZC1vZi1lYXJuaW5ncy1zZWUtdHdvLWRpdmlkZW5kLXN0b2Nrcy1oZS1pcy1hbHNvLXRyYWRpbmctMTAzMTc5NjcwONIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVhYelkzV1MxM1UxaHZaRlJEVFJEQ0FSaURBaWdCTWdZVldKWm9wZ2c=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "MRTX Stock Crashes As Amgen Rivalry Heats Up With New Lung Cancer Data", "desc": null, "date": "06/12/2022", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L21ydHgtc3RvY2stY3Jhc2hlcy1hcy1hbWdlbi1yaXZhbHJ5LWhlYXRzLXVwLXdpdGgtbmV3LWx1bmctY2FuY2VyLWRhdGEv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVFjMVI1WkZOeVh6ZzRPRlZuVFJDcEFSaXJBaWdCTWdZQkFZaWdnd3c=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "Amgen Stock: Here's What We Know About Its Belated Obesity Treatment", "desc": null, "date": "08/12/2022", "link": "news.google.com/articles/CBMib2h0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2FtZ2VuLXN0b2NrLWhlcmUtaXMtd2hhdC13ZS1rbm93LWFib3V0LWl0cy1iZWxhdGVkLW9iZXNpdHktdHJlYXRtZW50L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDNVRlJYVVVrdFFrSjBVM2swVFJDb0FSaXNBaWdCTWdrTmdwU0dMaWc5NndF=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "How Covid, 'industrial logic' and a threat played out in a multibillion-dollar biotech merger - San Francisco Business ...", "desc": null, "date": "01/09/2022", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDIyLzA5LzAxL2FtZ2VuLWNoZW1vY2VudHJ5eC1hbWduLWNjeGktdGF2bmVvcy1tZXJnZXItYnV5b3V0Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU9URkJzYm13MmNtTXdVRGw0VFJDb0FSaXNBaWdCTWdhdFZaRE9xUWM=-w200-h112-p-df", "media": "San Francisco Business Times ", "site": null, "reporter": "Ron Leuty", "sentiment": "negative"}, {"title": "StockWatch: Horizon Soars on Talks with Amgen, J&J, Sanofi", "desc": null, "date": "01/12/2022", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2dlbi1lZGdlL3N0b2Nrd2F0Y2gtaG9yaXpvbi1zb2Fycy1vbi10YWxrcy13aXRoLWFtZ2VuLWpqLXNhbm9maS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVNibXRNZW5sMGJGTTVVWE5DVFJDdkFSaWdBaWdCTWdhTkk1SlFsUWs=-w200-h112-p-df", "media": "Genetic Engineering & Biotechnology News", "site": null, "reporter": "Alex Philippidis", "sentiment": "positive"}, {"title": "ChemoCentryx Stock More Than Doubles On $4B Buyout", "desc": null, "date": "04/08/2022", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9jaGVtb2NlbnRyeXgtc3RvY2stbW9yZS1kb3VibGVzLTRiLTEzMDUyNzY3MS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUJTMnB3UWtwSGRqZEJZVlpDVFJDM0FSaVRBaWdCTWdZVmM0NklMUVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen's AMG-133 on a trajectory to compete with Novo Nordisk and Lilly", "desc": null, "date": "23/12/2022", "link": "news.google.com/articles/CBMif2h0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9hbWdlbi1zLWFtZy0xMzMtb24tYS10cmFqZWN0b3J5LXRvLWNvbXBldGUtd2l0aC1ub3ZvLW5vcmRpc2stYW5kLWxpbGx5LWluLW9iZXNpdHktc3BhY2XSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUJVamt3U3pGSFJWWjVPWGx1VFJDM0FSaVRBaWdCTWdZQmdJcXl4QVE=-w200-h112-p-df", "media": "The Pharma Letter", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Every stock trade Rep. Marjorie Taylor Greene and her husband have made since 2021", "desc": null, "date": "29/09/2022", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vd3d3LmJ1c2luZXNzaW5zaWRlci5jb20vbXRnLW1hcmpvcmllLXRheWxvci1ncmVlbmUtc3RvY2staW52ZXN0bWVudHMtY29uZ3Jlc3MtMjAyMi030gFgaHR0cHM6Ly93d3cuYnVzaW5lc3NpbnNpZGVyLmNvbS9tdGctbWFyam9yaWUtdGF5bG9yLWdyZWVuZS1zdG9jay1pbnZlc3RtZW50cy1jb25ncmVzcy0yMDIyLTc_YW1w?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXFNMFJPWVhSUWJtODFPSHBaVFJEQ0FSaURBaWdCTWdZeFJKSnZwUWM=-w200-h112-p-df", "media": "Business Insider", "site": null, "reporter": "Madison Hall", "sentiment": "positive"}, {"title": "CYTK Stock: Why CEO Robert Blum Says It's OK Cytokinetics Isn't An Overnight Success", "desc": null, "date": "27/10/2022", "link": "news.google.com/articles/CBMigAFodHRwczovL3d3dy5pbnZlc3RvcnMuY29tL25ld3MvdGVjaG5vbG9neS9jeXRrLXN0b2NrLXdoeS1jZW8tcm9iZXJ0LWJsdW0tc2F5cy1pdC1pcy1vay1jeXRva2luZXRpY3MtaXMtbm90LWFuLW92ZXJuaWdodC1zdWNjZXNzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZkVVE0UVRjdFIzRndSa3M1VFJDb0FSaXNBaWdCTWdheGhJaVB1UVE=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "What This News Might Mean for Amgen", "desc": null, "date": "31/08/2022", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIyLzA4LzMxL3doYXQtdGhpcy1uZXdzLW1pZ2h0LW1lYW4tZm9yLWFtZ2VuL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXFYM2xyY21OTFVWbG1aVXBPVFJDa0FSaXpBaWdCTWdhUlE0eG9JZ2c=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Natalie Forbes", "sentiment": "negative"}, {"title": "Top Research Reports for Novo Nordisk, Amgen & ADP", "desc": null, "date": "16/11/2022", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vdWsubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL3RvcC1yZXNlYXJjaC1yZXBvcnRzLW5vdm8tbm9yZGlzay0yMTI2MDkxOTUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDNiSGwxVFcxQ1prbGpaMEV0VFJDeUFSaWJBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo News UK", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "The 7 Best Retirement Stocks to Buy Now", "desc": null, "date": "18/12/2022", "link": "news.google.com/articles/CBMiMWh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vYmVzdC1yZXRpcmVtZW50LXN0b2Nrcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXFkREk1WjNoeFIwOUZkMUZzVFJDb0FSaXNBaWdCTWdZbEZZeXRrUWs=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Louis Navellier", "sentiment": "positive"}, {"title": "AMGEN AND TSCAN THERAPEUTICS ANNOUNCE COLLABORATION TO IDENTIFY NOVEL TARGETS IN CROHN'S ...", "desc": null, "date": "09/05/2023", "link": "news.google.com/articles/CBMilwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLWFuZC10c2Nhbi10aGVyYXBldXRpY3MtYW5ub3VuY2UtY29sbGFib3JhdGlvbi10by1pZGVudGlmeS1ub3ZlbC10YXJnZXRzLWluLWNyb2hucy1kaXNlYXNlLTMwMTgxODU1Mi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "US Challenge to Amgen Deal Threatens Big Pharma Business Model", "desc": null, "date": "16/05/2023", "link": "news.google.com/articles/CBMif2h0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIzLTA1LTE2L2Z0Yy1jaGFsbGVuZ2UtdG8tYW1nZW4tYW1nbi1ob3Jpem9uLWRlYWwtdGhyZWF0ZW5zLWJpZy1waGFybWEtYnVzaW5lc3MtbW9kZWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNVBXRjkyWmtoWFYyazFUWEJDVFJDM0FSaVRBaWdCTWdzQnNJU3JQV1k5OUZoc1RR=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Ike Swetlitz", "sentiment": "negative"}, {"title": "AMGN Earnings: Everything you need to know about Amgen\u2019s Q1 results", "desc": null, "date": "28/04/2023", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vYW1nbi1lYXJuaW5ncy1ldmVyeXRoaW5nLXlvdS1uZWVkLXRvLWtub3ctYWJvdXQtYW1nZW5zLXExLXJlc3VsdHMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUtkRzFSUWpOZmNVZG9SRk5LVFJDa0FoaXRBU2dCTWdZQk1ZakdKQVk=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGN: 3 Biotech Stocks With Potential to Be Big Winners in 2023", "desc": null, "date": "03/03/2023", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2FtZ24tYmlpYi1qYXp6LWliYi16eW1lLTMtYmlvdGVjaC1zdG9ja3Mtd2l0aC1wb3RlbnRpYWwtdG8tYmUtYmlnLXdpbm5lcnMtaW4v0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHpiWEJyYTNKTWFIUkRiVGxOVFJEREFSaURBaWdCTWdZWkFJcEpBZ3c=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Malaika Alphonsus", "sentiment": "positive"}, {"title": "Why Amgen Shares Are Trading Lower Today", "desc": null, "date": "28/04/2023", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy93aHktYW1nZW4tc2hhcmVzLXRyYWRpbmctbG93ZXItMTQ1ODQxMzY0Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUtkbkYxWnkxMUxWY3RaelZNVFJDb0FSaXNBaWdCTWdhTm9aSXZ2UVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN WINS PATENT APPEAL ON OTEZLA\u00ae (APREMILAST)", "desc": null, "date": "19/04/2023", "link": "news.google.com/articles/CBMiZWh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4td2lucy1wYXRlbnQtYXBwZWFsLW9uLW90ZXpsYS1hcHJlbWlsYXN0LTMwMTgwMjM1Ny5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Is Amgen a Good Dividend Stock?", "desc": null, "date": "01/06/2023", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzA2LzAxL2lzLWFtZ2VuLWEtZ29vZC1kaXZpZGVuZC1zdG9jay_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNWZMVlJsTFc1WWJGaGxNRWxHVFJDM0FSaVRBaWdCTWdrSlJKU0Z1aVprSmdJ=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "George Budwell", "sentiment": "negative"}, {"title": "FTC Sues to Block Amgen's Acquisition of Horizon Therapeutics", "desc": null, "date": "16/05/2023", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vZnRjLXN1ZXMtdG8tYmxvY2stYW1nZW4taG9yaXpvbi1kZWFsLTc0OTg5MjfSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNDNOR2szWjAxM1ptSlhZakJqVFJDM0FSaVRBaWdCTWd1Qk1JYW9JYU9hQlR0Vll3=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Mack Wilowski", "sentiment": "negative"}, {"title": "Lilly (LLY), Pfizer (PFE), Amgen (AMGN) Crowd Into Hot Obesity Drug Market", "desc": null, "date": "13/01/2023", "link": "news.google.com/articles/CBMidWh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIzLTAxLTEzL2xpbGx5LWxseS1wZml6ZXItcGZlLWFtZ2VuLWFtZ24tY3Jvd2QtaW50by1ob3Qtb2Jlc2l0eS1kcnVnLW1hcmtldNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZWR3hrYzFwa1VIVmpSRlJDVFJDdkFSaWdBaWdCTWdhQkJKVE5nUXM=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Emma Court & Robert Langreth", "sentiment": "negative"}, {"title": "Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know", "desc": null, "date": "09/06/2023", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvYW1nZW4tYW1nbi1zdG9jay1zaW5rcy1tYXJrZXQtMjE1MDIzNDUzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXRja2wyZFZaRlRXNXZhRGRxVFJDOUFSaUxBaWdCTWdhQlVZcTFNQVk=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "FDA GRANTS FULL APPROVAL FOR BLINCYTO\u00ae (BLINATUMOMAB) TO TREAT MINIMAL RESIDUAL DISEASE ...", "desc": null, "date": "21/06/2023", "link": "news.google.com/articles/CBMiwwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2ZkYS1ncmFudHMtZnVsbC1hcHByb3ZhbC1mb3ItYmxpbmN5dG8tYmxpbmF0dW1vbWFiLXRvLXRyZWF0LW1pbmltYWwtcmVzaWR1YWwtZGlzZWFzZS1wb3NpdGl2ZS1iLWNlbGwtcHJlY3Vyc29yLWFjdXRlLWx5bXBob2JsYXN0aWMtbGV1a2VtaWEtMzAxODU2MTI4Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Dips More Than Broader Markets: What You Should Know", "desc": null, "date": "09/01/2023", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2FtZ2VuLWFtZ24tZGlwcy1tb3JlLWJyb2FkZXItMjI1MDEwMjM1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVpWMEpTVFhGWVdFUnlNbUZQVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN ANNOUNCES CARDIOVASCULAR STUDY TO EVALUATE ASSOCIATION BETWEEN LIPOPROTEIN(a) AND ...", "desc": null, "date": "22/02/2023", "link": "news.google.com/articles/CBMitgFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLWFubm91bmNlcy1jYXJkaW92YXNjdWxhci1zdHVkeS10by1ldmFsdWF0ZS1hc3NvY2lhdGlvbi1iZXR3ZWVuLWxpcG9wcm90ZWluYS1hbmQtY2FyZGlvdmFzY3VsYXItcmlzay1pbi1hZnJpY2FuLWFtZXJpY2Fucy0zMDE3NTIxNDkuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMJEVITA\u2122 (ADALIMUMAB-ATTO), FIRST BIOSIMILAR TO HUMIRA\u00ae, NOW AVAILABLE IN THE UNITED STATES", "desc": null, "date": "31/01/2023", "link": "news.google.com/articles/CBMijgFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtamV2aXRhLWFkYWxpbXVtYWItYXR0by1maXJzdC1iaW9zaW1pbGFyLXRvLWh1bWlyYS1ub3ctYXZhaWxhYmxlLWluLXRoZS11bml0ZWQtc3RhdGVzLTMwMTczNDE3Ny5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN TO PRESENT NEW REPATHA\u00ae (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC", "desc": null, "date": "01/03/2023", "link": "news.google.com/articles/CBMieWh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tdG8tcHJlc2VudC1uZXctcmVwYXRoYS1ldm9sb2N1bWFiLWFuZC1vbHBhc2lyYW4tZGF0YS1hdC1hY2MtMzAxNzU5MTQxLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUNNMU14WjJ0clVsOWhVVWhSVFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Layoffs 2023: What to Know About the Latest AMGN Job Cuts", "desc": null, "date": "30/01/2023", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMy8wMS9hbWdlbi1sYXlvZmZzLTIwMjMtd2hhdC10by1rbm93LWFib3V0LXRoZS1sYXRlc3QtYW1nbi1qb2ItY3V0cy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDBXakZEVmtKSmRHdHZZMmxaVFJDb0FSaXNBaWdCTWdrQlFJQUgxaUZyU1FJ=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Shrey Dua", "sentiment": "negative"}, {"title": "Is AbbVie or Amgen the Better Bargain Buy Right Now?", "desc": null, "date": "08/06/2023", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzA2LzA4L2lzLWFiYnZpZS1vci1hbWdlbi10aGUtYmV0dGVyLWJhcmdhaW4tYnV5LXJpZ2h0LW5vL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZkR3d5TjA1M01IaE5ZazU0VFJDM0FSaVRBaWdCTWdhdDBJUzNVQU0=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "George Budwell", "sentiment": "negative"}, {"title": "Why Are TScan Therapeutics Shares Are Shooting Higher Today", "desc": null, "date": "09/05/2023", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy93aHktdHNjYW4tdGhlcmFwZXV0aWNzLXNoYXJlcy1zaG9vdGluZy0xNzI5MjAwMzMuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUJiRmxzTFRFd09EQTBaVzlHVFJDb0FSaXNBaWdCTWdZTmtwSklOUVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Are You a Value Investor? This 1 Stock Could Be the Perfect Pick", "desc": null, "date": "21/05/2023", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL3ZhbHVlLWludmVzdG9yLTEtc3RvY2stY291bGQtMTM0MDA3MTUzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDNRVUpQYjJkbFkzbDJlSFYzVFJDakFSaTFBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "TScan shares soar on news of Amgen deal worth a potential $530M - Boston Business Journal", "desc": null, "date": "10/05/2023", "link": "news.google.com/articles/CBMiZmh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9ib3N0b24vbmV3cy8yMDIzLzA1LzEwL3RzY2FuLXRoZXJhcGV1dGljcy1hbWdlbi1jb2xsYWItY3JvaG5zLWRpc2Vhc2UuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDNPRWxtZUVoQk9XcFRiMDFGVFJDb0FSaXNBaWdCTWdhQkJZek9qUW8=-w200-h112-p-df", "media": "Boston Business Journal", "site": null, "reporter": "Rowan Walrath", "sentiment": "negative"}, {"title": "FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?", "desc": null, "date": "24/05/2023", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzA1LzI0L2Z0Yy1ibG9jay1hbWdlbi1ob3Jpem9uLWRlYWwtcGZpemVyLXNlYWdlbi1yaXNrL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVJiMGxaVmt0dmVtNWxOWE5EVFJDM0FSaVRBaWdCTWdZaFU1QUxvZ2c=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "David Jagielski", "sentiment": "negative"}, {"title": "Biotech Stocks To Watch: Track The Latest News On Pharmaceutical Stocks And Drug Companies", "desc": null, "date": "13/05/2023", "link": "news.google.com/articles/CBMidGh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2Jpb3RlY2gtYW5kLXBoYXJtYS1pbmR1c3RyeS1hbmQtc3RvY2stbmV3cy1tZXJrLWJyaXN0b2wtbXllcnMtYW1nbi1naWxlYWQv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHpYMjlSVkhWdFIwbzJTVUZyVFJDcEFSaXJBaWdCTWdhWlFaRFZIQWs=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "How to Retire Rich: Biotech Stocks Edition", "desc": null, "date": "18/06/2023", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMy8wNi9ob3ctdG8tcmV0aXJlLXJpY2gtYmlvdGVjaC1zdG9ja3MtZWRpdGlvbi_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVZaVGxCUWxSMUxXZFdhWEZFVFJDb0FSaXNBaWdCTWdNQlV3dw=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Josh Enomoto", "sentiment": "positive"}, {"title": "Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents", "desc": null, "date": "03/05/2023", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi12cy1zYW5kb3otbGVnYWwtYmF0dGxlLTE1MDAyNTMwOS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUpTbTFuZFcweldXUk1lVmxTVFJDb0FSaXNBaWdCTWdhTm9aSXZ2UVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN ANNOUNCES 2023 FOURTH QUARTER DIVIDEND", "desc": null, "date": "24/10/2023", "link": "news.google.com/articles/CBMiZGh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tYW5ub3VuY2VzLTIwMjMtZm91cnRoLXF1YXJ0ZXItZGl2aWRlbmQtMzAxOTY2Mjk0Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUNNMU14WjJ0clVsOWhVVWhSVFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know", "desc": null, "date": "17/11/2023", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi1hdHRyYWN0aW5nLWludmVzdG9yLTE0MDAwNTcxOC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVpWMEpTVFhGWVdFUnlNbUZQVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMGEN ANNOUNCES EXECUTIVE APPOINTMENTS TO ACCELERATE INNOVATION", "desc": null, "date": "14/12/2023", "link": "news.google.com/articles/CBMid2h0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tYW5ub3VuY2VzLWV4ZWN1dGl2ZS1hcHBvaW50bWVudHMtdG8tYWNjZWxlcmF0ZS1pbm5vdmF0aW9uLTMwMjAxNTM5MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Here's Why Amgen (AMGN) is a Strong Value Stock", "desc": null, "date": "11/12/2023", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9oZXJlcy13aHktYW1nZW4tYW1nbi1zdHJvbmctMTQ0MDA3OTg1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXBNakZFWDBaUGRWQlRUMjVJVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer", "desc": null, "date": "13/12/2023", "link": "news.google.com/articles/CBMilwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2ZkYS1ncmFudHMtcHJpb3JpdHktcmV2aWV3LXRvLWFtZ2Vucy10YXJsYXRhbWFiLWFwcGxpY2F0aW9uLWZvci1hZHZhbmNlZC1zbWFsbC1jZWxsLWx1bmctY2FuY2VyLTMwMjAxNDYzOS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (NASDAQ:AMGN) shareholders have earned a 9.8% CAGR over the last five years", "desc": null, "date": "07/12/2023", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1uYXNkYXEtYW1nbi1zaGFyZWhvbGRlcnMtZWFybmVkLTExMDA1ODg1OC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdkakZCVjBobVZuUmFhbFkyVFJDSEFSajJBaWdCTWdZQkFvYlZnQXc=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMGEN TO DISCUSS APPLICATION FOR LUMAKRAS\u00ae (SOTORASIB) FOR THE TREATMENT OF KRAS G12C ...", "desc": null, "date": "21/08/2023", "link": "news.google.com/articles/CBMiuwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLXRvLWRpc2N1c3MtYXBwbGljYXRpb24tZm9yLWx1bWFrcmFzLXNvdG9yYXNpYi1mb3ItdGhlLXRyZWF0bWVudC1vZi1rcmFzLWcxMmMtcG9zaXRpdmUtbnNjbGMtYXQtZmRhLWFkdmlzb3J5LWNvbW1pdHRlZS1tZWV0aW5nLTMwMTkwNTk1Ni5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "FDA Rejects Amgen's (AMGN) NDA Seeking Full Nod for Lumakras", "desc": null, "date": "27/12/2023", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9mZGEtcmVqZWN0cy1hbWdlbnMtYW1nbi1uZGEtMTYwOTAwMjA0Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFjamMwT1ZwMU5tMUxRV05WVFJDeUFSaWJBaWdCTWdZWlU0b3NKUVU=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH ...", "desc": null, "date": "02/11/2023", "link": "news.google.com/articles/CBMioAFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLXByZXNlbnRzLW5ldy1kYXRhLXRoYXQtc2hvdy1ibG9vZC1wcmVzc3VyZS1kZWNyZWFzZXMtZm9yLWFkdWx0cy10cmVhdGVkLXdpdGgta3J5c3RleHhhLXBlZ2xvdGljYXNlLTMwMTk3NDk3MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVFiSGxSWTBvM05uQm1aVlZKVFJDaUFSaTJBaWdCTWdhZG81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Is Amgen Inc (AMGN) Stock Fairly Valued?", "desc": null, "date": "08/08/2023", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi1zdG9jay1mYWlybHktMTYzMzQwMzg0Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDJSMlZQTjBFMk4yZGFOMjl5VFJEaEFSamhBU2dCTWdZRnNaVFZ2QWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND PIPELINE AT ESMO 2023", "desc": null, "date": "16/10/2023", "link": "news.google.com/articles/CBMihwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLXRvLXByZXNlbnQtbmV3LXJlc2VhcmNoLWZyb20tb25jb2xvZ3ktcG9ydGZvbGlvLWFuZC1waXBlbGluZS1hdC1lc21vLTIwMjMtMzAxOTU2ODUwLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen (AMGN) Stock Moves -0.15%: What You Should Know", "desc": null, "date": "29/12/2023", "link": "news.google.com/articles/CBMiRmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLXN0b2NrLW1vdmVzLTAtMjI1MDIwNTE5Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWFNVVIwVFV4a2FHVjRjRWhIVFJDM0FSaVRBaWdCTWdZbEJwRHNBUTA=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN PRESENTS LATE-BREAKING PHASE 2 OLPASIRAN DATA AT ESC 2023", "desc": null, "date": "26/08/2023", "link": "news.google.com/articles/CBMid2h0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tcHJlc2VudHMtbGF0ZS1icmVha2luZy1waGFzZS0yLW9scGFzaXJhbi1kYXRhLWF0LWVzYy0yMDIzLTMwMTkxMDQzNi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Inc. (NASDAQ:AMGN) Q3 2023 Earnings Call Transcript", "desc": null, "date": "01/11/2023", "link": "news.google.com/articles/CBMiRmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtbmFzZGFxLWFtZ24tcTMtMTQzMTQ4ODA2Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUphbEV0WW1zNVoyNWtYMUExVFJDb0FSaXNBaWdCTWdZWkpvUm9sZ2s=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Insider Monkey", "sentiment": "negative"}, {"title": "AMGEN PRESENTS NEW LUMAKRAS\u00ae (SOTORASIB) PLUS VECTIBIX\u00ae (PANITUMUMAB) DATA IN PATIENTS ...", "desc": null, "date": "22/10/2023", "link": "news.google.com/articles/CBMivAFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLXByZXNlbnRzLW5ldy1sdW1ha3Jhcy1zb3RvcmFzaWItcGx1cy12ZWN0aWJpeC1wYW5pdHVtdW1hYi1kYXRhLWluLXBhdGllbnRzLXdpdGgta3Jhcy1nMTJjLW11dGF0ZWQtbWV0YXN0YXRpYy1jb2xvcmVjdGFsLWNhbmNlci0zMDE5NjM3OTEuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Amgen Inc (AMGN) Company: A Short SWOT Analysis", "desc": null, "date": "02/11/2023", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi1jb21wYW55LXNob3J0LTA1MDgwODMyMi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVNblp0YkhVemVHMHdaR0ZUVFJEaEFSamhBU2dCTWdZRnNaVFZ2QWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023", "desc": null, "date": "10/11/2023", "link": "news.google.com/articles/CBMibmh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tcHJlc2VudHMtbmV3LWNhcmRpb3Zhc2N1bGFyLXJlc2VhcmNoLWF0LWFoYS0yMDIzLTMwMTk4NDEyNC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Is Amgen Inc (AMGN) Stock Fairly Valued? An In-depth Analysis", "desc": null, "date": "04/08/2023", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi1zdG9jay1mYWlybHktMTYzMjU4MTA3Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDJSMlZQTjBFMk4yZGFOMjl5VFJEaEFSamhBU2dCTWdZRnNaVFZ2QWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN SJ\u00d6GREN'S SYNDROME AT ACR 2023", "desc": null, "date": "07/11/2023", "link": "news.google.com/articles/CBMikgFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtZ2VuLXByZXNlbnRzLW5ldy1kYXRhLWZyb20tcGhhc2UtMi10cmlhbC1vZi1kYXpvZGFsaWJlcC1pbi1zam9ncmVucy1zeW5kcm9tZS1hdC1hY3ItMjAyMy0zMDE5NzkyMDguaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen (NASDAQ:AMGN) shareholders have earned a 5.8% CAGR over the last five years", "desc": null, "date": "07/07/2023", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1uYXNkYXEtYW1nbi1zaGFyZWhvbGRlcnMtZWFybmVkLTEyMDAzODk1My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdkakZCVjBobVZuUmFhbFkyVFJDSEFSajJBaWdCTWdZQkFvYlZnQXc=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Is Amgen Stock a Buy Now?", "desc": null, "date": "17/12/2023", "link": "news.google.com/articles/CBMiQ2h0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzEyLzE3L2lzLWFtZ2VuLXN0b2NrLWEtYnV5LW5vdy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUNiRU4xVVZKSldrRnpOalY0VFJDM0FSaVRBaWdCTWdhUmxvUUhzZ1k=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Sales Drive Profit Guidance Even as New Drugs Falter", "desc": null, "date": "03/08/2023", "link": "news.google.com/articles/CBMieGh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIzLTA4LTAzL2FtZ2VuLWFtZ24tcmFpc2VzLTIwMjMtcHJvZml0LXNhbGVzLWd1aWRhbmNlLWV2ZW4tYXMta2V5LWRydWdzLWZhbHRlctIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHhaMUphZVhsbllVbG1hVWhNVFJDM0FSaVRBaWdCTWdZTmtvcE1NUWM=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Ike Swetlitz", "sentiment": "negative"}, {"title": "Amgen (NASDAQ:AMGN) Seems To Use Debt Quite Sensibly", "desc": null, "date": "28/07/2023", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1uYXNkYXEtYW1nbi1zZWVtcy1kZWJ0LTEyMDA0NjYzMC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlObXRQY2toalptNXBialZOVFJDMEFSaVpBaWdCTWdZTkFZelZDQXc=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Here's Why We Think Amgen (NASDAQ:AMGN) Might Deserve Your Attention Today", "desc": null, "date": "11/12/2023", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9oZXJlcy13aHktdGhpbmstYW1nZW4tbmFzZGFxLTEzMDAxMzQyOS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdkakZCVjBobVZuUmFhbFkyVFJDSEFSajJBaWdCTWdZQkFvYlZnQXc=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen Inc (AMGN) Q3 2023 Earnings: Revenue Up 4% to $6.9 Billion, GAAP EPS Down 19% to $3.22", "desc": null, "date": "31/10/2023", "link": "news.google.com/articles/CBMiRGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi1xMy0yMDIzLTEyMzI1NDIzNC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVFUMU5RYTFseVdYZHNURFpmVFJEaEFSamhBU2dCTWdZRnNaVFVQQWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGN: Amgen (AMGN) Earnings Watch: Buy or Sell?", "desc": null, "date": "30/10/2023", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2FtZ24tZ2lsZC1qYXp6LWFsa3MtYW1nZW4tYW1nbi1lYXJuaW5ncy13YXRjaC1idXktb3Itc2VsbC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNUpTRU4wUzAxSFlrTlRXa1UxVFJDNkFSaU9BaWdCTWdPSnNSSQ=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Dipanjan Banchur", "sentiment": "negative"}, {"title": "Amgen (AMGN) Valuation: A Comprehensive Analysis of Its Market Value", "desc": null, "date": "10/10/2023", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLXZhbHVhdGlvbi1jb21wcmVoZW5zaXZlLWFuYWx5c2lzLTE1MzYxNDI1MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVNblp0YkhVemVHMHdaR0ZUVFJEaEFSamhBU2dCTWdZRnNaVFZ2QWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "FTC Allows Amgen (AMGN) to Proceed With $28B Horizon Buyout", "desc": null, "date": "04/09/2023", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9mdGMtYWxsb3dzLWFtZ2VuLWFtZ24tcHJvY2VlZC0xNjE0MDAxODAuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDNTbTVMWkhBMVVVdFVkVkZvVFJDeUFSaWJBaWdCTWdZRnNaQU12UVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN)'s True Worth: A Complete Analysis of Its Market Value", "desc": null, "date": "20/09/2023", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLXRydWUtd29ydGgtY29tcGxldGUtMjMzMjU1NjMwLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVNblp0YkhVemVHMHdaR0ZUVFJEaEFSamhBU2dCTWdZRnNaVFZ2QWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more", "desc": null, "date": "11/10/2023", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjMvMTAvMTEvc3RvY2tzLW1ha2luZy10aGUtYmlnZ2VzdC1tb3Zlcy1taWRkYXktLmh0bWzSAVBodHRwczovL3d3dy5jbmJjLmNvbS9hbXAvMjAyMy8xMC8xMS9zdG9ja3MtbWFraW5nLXRoZS1iaWdnZXN0LW1vdmVzLW1pZGRheS0uaHRtbA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNVJhRXN0TXpGQldtOVVaMDAzVFJDb0FSaXNBaWdCTWdrWkE1QXh0U2FTcFFJ=-w200-h112-p-df", "media": "CNBC", "site": null, "reporter": "Michelle Fox", "sentiment": "positive"}, {"title": "Amgen (AMGN) Q2 Earnings Beat Estimates, 2023 View Raised", "desc": null, "date": "04/08/2023", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLXEyLWVhcm5pbmdzLWJlYXQtMTYxMjAwMjAzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWpVbWd5TlU1WlRqVTBkek5tVFJDeUFSaWJBaWdCTWdhTk40cUdIZ1k=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (NASDAQ:AMGN) Gains on New AWS Partnership - TipRanks.com", "desc": null, "date": "28/11/2023", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vd3d3LnRpcHJhbmtzLmNvbS9uZXdzL2FtZ2VuLW5hc2RhcWFtZ24tZ2FpbnMtd2l0aC1uZXctYXdzLXBhcnRuZXJzaGlw0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVBjVXA1TjNGc0xWZ3RWMTh4VFJDbEFSaXhBaWdCTWdhZHM1S0x1UVk=-w200-h112-p-df", "media": "TipRanks", "site": null, "reporter": "Steve Anderson", "sentiment": "negative"}, {"title": "Is Amgen Stock Fully Valued After A 17% Rise In A Month?", "desc": null, "date": "14/08/2023", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMy8wOC8xNC9pcy1hbWdlbi1zdG9jay1mdWxseS12YWx1ZWQtYWZ0ZXItYS0xNy1yaXNlLWluLWEtbW9udGgv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHpablUzUlVwRE1qaFNRVWRVVFJDM0FSaVRBaWdCTWdhRjlJYnBTUVE=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Is Amgen Stock a Top Buy and Hold?", "desc": null, "date": "21/08/2023", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzA4LzIxL2lzLWFtZ2VuLXN0b2NrLWEtdG9wLWJ1eS1hbmQtaG9sZC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNUZka0ZqTWpKMmFXWnBVV0UzVFJDM0FSaVRBaWdCTWdzQklKREFIR2dzSkN0b2RB=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "George Budwell", "sentiment": "negative"}, {"title": "Amgen Stock (AMGN) Stock Falls on Sales Guidance", "desc": null, "date": "31/10/2023", "link": "news.google.com/articles/CBMib2h0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIzLTEwLTMxL2FtZ2VuLXJhaXNlcy1yZXZlbnVlLWd1aWRhbmNlLWFmdGVyLWNsb3NpbmctaG9yaXpvbi1wdXJjaGFzZdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVSUzFHVWt0M1pqRnZaekp1VFJDM0FSaVRBaWdCTWdZQlFwSU9wUWM=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Ike Swetlitz", "sentiment": "negative"}, {"title": "AMGN Earnings: Everything you need to know about Amgen\u2019s Q2 results", "desc": null, "date": "04/08/2023", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vYW1nbi1lYXJuaW5ncy1ldmVyeXRoaW5nLXlvdS1uZWVkLXRvLWtub3ctYWJvdXQtYW1nZW5zLXEyLXJlc3VsdHMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUdTRUpGUVhKRGJuVm1RbGxLVFJDa0FoaXRBU2dCTWdZQk1ZaklKQVk=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Inc's Dividend Analysis", "desc": null, "date": "15/11/2023", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmNzLWRpdmlkZW5kLWFuYWx5c2lzLTEwMDYxMTQ3OS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVNblp0YkhVemVHMHdaR0ZUVFJEaEFSamhBU2dCTWdZRnNaVFZ2QWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Top Stock Reports for McDonald's, Amgen & NextEra Energy", "desc": null, "date": "29/11/2023", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy90b3Atc3RvY2stcmVwb3J0cy1tY2RvbmFsZHMtYW1nZW4tMTk1MjAwMDk5Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNVFNMEo1VGpWbWJGY3hZVUU1VFJDM0FSaVRBaWdCTWdrQmdJU0F4R05UMlFB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Sheraz Mian", "sentiment": "positive"}, {"title": "AMGN: 3 Biotech Stocks Beating BioMarin Pharmaceutical (BMRN)", "desc": null, "date": "16/11/2023", "link": "news.google.com/articles/CBMiZWh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2FtZ24tdnJ0eC1qYXp6LWJtcm4tMy1iaW90ZWNoLXN0b2Nrcy1iZWF0aW5nLWJpb21hcmluLXBoYXJtYWNldXRpY2FsLWJtcm4v0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUtZMmwyWVcxVU1VUnpVR2hzVFJDakFSaTJBaWdCTWdZTkJZS3VrUWs=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Dipanjan Banchur", "sentiment": "negative"}, {"title": "Can Amgen's Price Strength Continue Into 2024?", "desc": null, "date": "29/12/2023", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vcHJvLnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL2Nhbi1hbWdlbi1zLXByaWNlLXN0cmVuZ3RoLWNvbnRpbnVlLWludG8tMjAyNC0xNjE0MTA1NNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXlNRXBhVEc5aVJVZFdRbTh0VFJEd0FSalNBU2dCTWdrQklZcm1sQ2xrRFFF=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Bruce Kamich", "sentiment": "negative"}, {"title": "Which Is A Better Pick \u2013 Abbott Stock Or Amgen?", "desc": null, "date": "16/10/2023", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMy8xMC8xNi93aGljaC1pcy1hLWJldHRlci1waWNrLS1hYmJvdHQtc3RvY2stb3ItYW1nZW4v0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTNhbXhTWHpoVlJFcGpOWGxEVFJDM0FSaVRBaWdCTWdheFlJelNLQVU=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGN Earnings: Highlights of Amgen\u2019s Q3 2023 financial results", "desc": null, "date": "31/10/2023", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vYW1nbi1lYXJuaW5ncy1oaWdobGlnaHRzLW9mLWFtZ2Vucy1xMy0yMDIzLWZpbmFuY2lhbC1yZXN1bHRzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUJRMjVHTjBvdFNWOVVjVzFrVFJDa0FoaXRBU2dCTWdrQk1ZYktwT1d4Q2dJ=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Layoffs 2023: What to Know About the Latest AMGN Job Cuts", "desc": null, "date": "24/10/2023", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMy8xMC9hbWdlbi1sYXlvZmZzLTIwMjMtd2hhdC10by1rbm93LWFib3V0LXRoZS1sYXRlc3QtYW1nbi1qb2ItY3V0cy0yL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDBXakZEVmtKSmRHdHZZMmxaVFJDb0FSaXNBaWdCTWdrQlFJQUgxaUZyU1FJ=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Chris Macdonald", "sentiment": "negative"}, {"title": "Which Is A Better Pick \u2013 Honeywell Stock Or Amgen?", "desc": null, "date": "11/09/2023", "link": "news.google.com/articles/CBMia2h0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMy8wOS8xMS93aGljaC1pcy1hLWJldHRlci1waWNrLS1ob25leXdlbGwtc3RvY2stb3ItYW1nZW4v0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWZXbEU0Um1GU1dFTjJjSFZNVFJDM0FSaVRBaWdCTWdhcDFJaXVSUVE=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (NASDAQ:AMGN) Delivers Better-than-Expected Q3 Earnings - TipRanks.com", "desc": null, "date": "31/10/2023", "link": "news.google.com/articles/CBMiWGh0dHBzOi8vd3d3LnRpcHJhbmtzLmNvbS9uZXdzL2FtZ2VuLW5hc2RhcWFtZ24tZGVsaXZlcnMtYmV0dGVyLXRoYW4tZXhwZWN0ZWQtcTMtZWFybmluZ3PSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXhlazF2V2taVFZHcFVhR0pmVFJDbEFSaXhBaWdCTWdZQlFKQ3VMUVk=-w200-h112-p-df", "media": "TipRanks", "site": null, "reporter": "Shrilekha Pethe", "sentiment": "negative"}, {"title": "Here's Why Intuit Stock Is A Better Pick Over Amgen", "desc": null, "date": "03/10/2023", "link": "news.google.com/articles/CBMibWh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMy8xMC8wMy9oZXJlcy13aHktaW50dWl0LXN0b2NrLWlzLWEtYmV0dGVyLXBpY2stb3Zlci1hbWdlbi_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUZZV05YYlV4dlNHaGtRVFUyVFJDMkFSaVVBaWdCTWdZSmc0eG9yUWM=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Amgen Inc (AMGN) Company: A Short SWOT Analysis", "desc": null, "date": "02/11/2023", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vd3d3Lmd1cnVmb2N1cy5jb20vbmV3cy8yMTE2NzU1L3RoZS1hbWdlbi1pbmMtYW1nbi1jb21wYW55LWEtc2hvcnQtc3dvdC1hbmFseXNpc9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVNblp0YkhVemVHMHdaR0ZUVFJEaEFSamhBU2dCTWdZRnNaVFZ2QWM=-w200-h112-p-df", "media": "GuruFocus.com", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Appoints Matthew C. Busch as Chief Accounting Officer", "desc": null, "date": "04/08/2023", "link": "news.google.com/articles/CBMigQFodHRwczovL3d3dy5zdHJlZXRpbnNpZGVyLmNvbS9Db3Jwb3JhdGUrTmV3cy9BbWdlbislMjhBTUdOJTI5K0FwcG9pbnRzK01hdHRoZXcrQy4rQnVzY2grYXMrQ2hpZWYrQWNjb3VudGluZytPZmZpY2VyLzIxOTk3NjMyLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXlWbGRDUTJacGRFNVNTR2MwVFJESUFSaklBU2dCTWdNSnNCUQ=-w200-h112-p-df", "media": "StreetInsider.com", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "FTC suspends challenge to Amgen-Horizon Therapeutics deal", "desc": null, "date": "28/08/2023", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vdmlkZW8vZnRjLXN1c3BlbmRzLWNoYWxsZW5nZS1hbWdlbi1ob3Jpem9uLTE1NDI1NTQ5My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUNSWGR3WldsUGQwZzVTVkZXVFJDb0FSaXJBaWdCTWdrQlVvNHRyV2FhcndF=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Stephanie Mikulich", "sentiment": "negative"}, {"title": "Which Is A Better Pick \u2013 PepsiCo Stock Or Amgen?", "desc": null, "date": "26/09/2023", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMy8wOS8yNi93aGljaC1pcy1hLWJldHRlci1waWNrLS1wZXBzaWNvLXN0b2NrLW9yLWFtZ2VuL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNUZaa3hGUldaUE5XRnpVazV1VFJDM0FSaVRBaWdCTWdzQklJcUVKS1lzVkVua3VR=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Zacks Analyst Blog Highlights McDonald's, Amgen, NextEra Energy, General Mills and Take-Two Interactive ...", "desc": null, "date": "30/11/2023", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy96YWNrcy1hbmFseXN0LWJsb2ctaGlnaGxpZ2h0cy1tY2RvbmFsZHMtMTUxNjAwMzIwLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUhTWEJxWjJKdFdrZFZYMkV6VFJDM0FSaVRBaWdCTWdtSlFwQkhxZWFSeUFJ=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It", "desc": null, "date": "25/09/2023", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vY2Euc3R5bGUueWFob28uY29tL3N0eWxlL2FtZ2VuLWluYy1hbWduLXRyZW5kaW5nLXN0b2NrLTEzMDAwNzAwMy5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUdiV1k0ZEVsVVZHUktPR0p1VFJETUFSajNBU2dCTWdB=-w200-h112-p-df", "media": "Yahoo Canada Shine On", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Why Amgen (AMGN) is a Top Value Stock for the Long-Term", "desc": null, "date": "28/08/2023", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vdWsubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL3doeS1hbWdlbi1hbWduLXRvcC12YWx1ZS0xMzQwMDQ5MTIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTVNMEZNYWs0dE1uSkxaWGszVFJDaUFSaTNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo News UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "QUALCOMM, AIG And 2 Other Stocks Insiders Are Selling - Amgen (NASDAQ:AMGN), American Intl Gr (NYSE:AIG)", "desc": null, "date": "14/08/2023", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9uZXdzLzIzLzA4LzMzODI4MDk4L3F1YWxjb21tLWFpZy1hbmQtMi1vdGhlci1zdG9ja3MtaW5zaWRlcnMtYXJlLXNlbGxpbmfSAS1odHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvMzM4MjgwOTg?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTZTaTFGVTFONFUyUlhORkUyVFJDM0FSaVRBaWdCTWdZSm81Ym51UWM=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Lisa Levin", "sentiment": "positive"}, {"title": "3 Biotech Stocks to Buy in the TradeSmith 'Green Zone'", "desc": null, "date": "21/12/2023", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMy8xMi8zLWJpb3RlY2gtc3RvY2tzLXRvLWJ1eS1pbi10aGUtdHJhZGVzbWl0aC1ncmVlbi16b25lL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNXJSbE5DUVhWUE9ETTJkM05TVFJDb0FSaXNBaWdCTWdzQkFJVEZvT1lzQlV2c1hB=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Reports Q2 Earnings: What Key Metrics Have to Say", "desc": null, "date": "03/08/2023", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vdWsuc3R5bGUueWFob28uY29tL3N0eWxlL2FtZ2VuLWFtZ24tcmVwb3J0cy1xMi1lYXJuaW5ncy0yMzMwMDY0ODcuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVFNMEo1VGpWbWJGY3hZVUU1VFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Lifestyle UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Stock (AMGN) A Long-Term Investment or a Short-Term Play?", "desc": null, "date": "14/08/2023", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vd3d3LnRoZWNvaW5yZXB1YmxpYy5jb20vMjAyMy8wOC8xNC9hbWdlbi1zdG9jay1hbWduLWEtbG9uZy10ZXJtLWludmVzdG1lbnQtb3ItYS1zaG9ydC10ZXJtLXBsYXkv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTRjRlJhYlZWTWRtTnFjM1V5VFJDb0FSaXNBaWdCTWdZUmNZd091UVk=-w200-h112-p-df", "media": "The Coin Republic", "site": null, "reporter": "Pratik Chadhokar", "sentiment": "negative"}, {"title": "AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMieWh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tcmVwb3J0cy1mb3VydGgtcXVhcnRlci1hbmQtZnVsbC15ZWFyLTIwMjMtZmluYW5jaWFsLXJlc3VsdHMtMzAyMDU1MTMxLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZOREUxYW5JMGNUaHlWMWh1VFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It", "desc": null, "date": "29/03/2024", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi10cmVuZGluZy1zdG9jay0xMzAwMTAwODIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNVFNMEo1VGpWbWJGY3hZVUU1VFJDM0FSaVRBaWdCTWdrQmdJU0F4R05UMlFB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know", "desc": null, "date": "18/03/2024", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9pbnZlc3RvcnMtaGVhdmlseS1zZWFyY2gtYW1nZW4taW5jLTEzMDAxMTU0My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXhUVlpLV1RGelZUaGtXa3RhVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIO", "desc": null, "date": "26/02/2024", "link": "news.google.com/articles/CBMiemh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYW1nZW4tb3BlbnMtc3RhdGUtb2YtdGhlLWFydC1iaW9tYW51ZmFjdHVyaW5nLXNpdGUtaW4tY2VudHJhbC1vaGlvLTMwMjA3MDE2MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTVjRjl6Y2xRMVQzQk5jVGwwVFJDaUFSaTNBaWdCTWdNRm9SSQ=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know", "desc": null, "date": "23/02/2024", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi1hdHRyYWN0aW5nLWludmVzdG9yLTE0MDAxMDE2OS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVRUblZtTjI5NVl5MWFVMnBRVFJEQ0FSaURBaWdCTWdZcFJZN05JUWc=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock", "desc": null, "date": "06/03/2024", "link": "news.google.com/articles/CBMiR2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9rbm93LWJleW9uZC13aHktYW1nZW4taW5jLTE0MDAxMDczMy5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW9YMEpFWm1Wd1ZqVjVha2s0VFJDM0FSaVRBaWdCTWdZQmNJNExNZ2M=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It", "desc": null, "date": "03/01/2024", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi10cmVuZGluZy1zdG9jay0xNDAwMDY1MDAuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUxiMnhTUTJKRmNrNVFibDlWVFJES0FSajZBU2dCTWdhWmNZeHN1UVU=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Ascends While Market Falls: Some Facts to Note", "desc": null, "date": "25/03/2024", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLWFzY2VuZHMtd2hpbGUtbWFya2V0LTIxNTAxOTM1OS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVljblZMWkRkblRYQjFka3hMVFJDM0FSaVRBaWdCTWdZTlFaTFVMQWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Why Amgen (AMGN) Outpaced the Stock Market Today", "desc": null, "date": "18/03/2024", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy93aHktYW1nZW4tYW1nbi1vdXRwYWNlZC1zdG9jay0yMjAwMTgzNzUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW1jbGswYzBWRFVFNDFTWGRIVFJDM0FSaVRBaWdCTWdZSllJb0xxZ2c=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen Inc. (AMGN) Soars to 52-Week High, Time to Cash Out?", "desc": null, "date": "25/01/2024", "link": "news.google.com/articles/CBMiRWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi1zb2Fycy01Mi0xNDE1MDQxNjUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUlVSFZzUkZKaFRXNDJTWGd5VFJDeUFSaWJBaWdCTWdrdEFvd3Z0U1U5QUFN=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Down 6.5% Since Last Earnings Report: Can It Rebound?", "desc": null, "date": "07/03/2024", "link": "news.google.com/articles/CBMiQWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLWRvd24tNi01LTE2MzEwMzQzNi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWhjemQwUWsxdVpWcE9SWEo0VFJDM0FSaVRBaWdCTWdhQnNJeGtRZ1k=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Unlocking Q4 Potential of Amgen (AMGN): Exploring Wall Street Estimates for Key Metrics", "desc": null, "date": "01/02/2024", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy91bmxvY2tpbmctcTQtcG90ZW50aWFsLWFtZ2VuLWFtZ24tMTQxNTIxNDA1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDNRVUpQYjJkbFkzbDJlSFYzVFJDakFSaTFBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release", "desc": null, "date": "30/01/2024", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLWVhcm5pbmdzLWV4cGVjdGVkLWdyb3ctMTUwMDQ5NDQyLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNU5lVjkxTW1KclQySmlaMGxSVFJDNkFSaVBBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biotech Stock Roundup: GILD, AMGN & BMY's Q4 Results, MOR Up on NVS Deal & More", "desc": null, "date": "08/02/2024", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW90ZWNoLXN0b2NrLXJvdW5kdXAtZ2lsZC1hbWduLTE1NTYwMDU2Ni5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW1lVVJ6ZGtaTWFYVXdXamRQVFJDeUFSaWJBaWdCTWdZWjBJZ0tSUVE=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Inc (AMGN) Reports Strong Revenue Growth Amidst Horizon Acquisition", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1pbmMtYW1nbi1yZXBvcnRzLXN0cm9uZy0yMTUyMzAzODEuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVFUMU5RYTFseVdYZHNURFpmVFJEaEFSamhBU2dCTWdZRnNaVFVQQWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Drug, Biotech Stocks' Q4 Earnings Due on Feb 6: AMGN, LLY & More", "desc": null, "date": "05/02/2024", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9kcnVnLWJpb3RlY2gtc3RvY2tzLXE0LWVhcm5pbmdzLTE1MDkwMDE4OC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWhjR2RtWTJKQ1FqYzRNSEphVFJDeUFSaWJBaWdCTWdZTk1wcjBuQWs=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Q4 Earnings and Revenues Top Estimates", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLXE0LWVhcm5pbmdzLXJldmVudWVzLTIyMTAwNDU1My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTVNMEZNYWs0dE1uSkxaWGszVFJDaUFSaTNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Why the Market Dipped But Amgen (AMGN) Gained Today", "desc": null, "date": "04/01/2024", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy93aHktbWFya2V0LWRpcHBlZC1hbWdlbi1hbWduLTIzMDAxODk5NC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVpWMEpTVFhGWVdFUnlNbUZQVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Pinning Down Amgen Inc.'s (NASDAQ:AMGN) P/E Is Difficult Right Now", "desc": null, "date": "16/02/2024", "link": "news.google.com/articles/CBMiiwFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1hbWduL2FtZ2VuL25ld3MvcGlubmluZy1kb3duLWFtZ2VuLWluY3MtbmFzZGFxYW1nbi1wZS1pcy1kaWZmaWN1bHQtcmlnaHQtbm930gGPAWh0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvdXMvcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbmFzZGFxLWFtZ24vYW1nZW4vbmV3cy9waW5uaW5nLWRvd24tYW1nZW4taW5jcy1uYXNkYXFhbWduLXBlLWlzLWRpZmZpY3VsdC1yaWdodC1ub3cvYW1w?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdkakZCVjBobVZuUmFhbFkyVFJDSEFSajJBaWdCTWdZQkFvYlZnQXc=-w200-h112-p-df", "media": "Simply Wall St", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Is Amgen Stock a Buy Now?", "desc": null, "date": "01/02/2024", "link": "news.google.com/articles/CBMiQ2h0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDI0LzAyLzAxL2lzLWFtZ2VuLXN0b2NrLWEtYnV5LW5vdy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHdhSFoxUW5SNmVXWlViV014VFJDM0FSaVRBaWdCTWdhSlZaak5wUWc=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGN: AMGN Earnings Spotlight: Analyzing Potential Gains", "desc": null, "date": "05/02/2024", "link": "news.google.com/articles/CBMiYmh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2FtZ24taW5jeS1vdHNreS1jb3J0LWFtZ24tZWFybmluZ3Mtc3BvdGxpZ2h0LWFuYWx5emluZy1wb3RlbnRpYWwtZ2FpbnMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUpXRmcxY3pCRE9VcFhVemhJVFJDM0FSaVRBaWdCTWdhUllZSVFwUWM=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Anushka Mukherjee", "sentiment": "negative"}, {"title": "Amgen (AMGN) Sees 2024 Revenue Jump After Horizon Therapeutics Purchase", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDI0LTAyLTA2L2FtZ2VuLWV4cGVjdHMtYS0yMDI0LXNhbGVzLWp1bXAtc2V0cy1zaWdodHMtb24tb2Jlc2l0eS1tYXJrZXTSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNVBXRjkyWmtoWFYyazFUWEJDVFJDM0FSaVRBaWdCTWdzQnNJU3JQV1k5OUZoc1RR=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Madison Muller", "sentiment": "negative"}, {"title": "Amgen (AMGN) Reports Q4 Earnings: What Key Metrics Have to Say", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1hbWduLXJlcG9ydHMtcTQtZWFybmluZ3MtMDEwMDA2NzM1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXhUVlpLV1RGelZUaGtXa3RhVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen's (NASDAQ:AMGN) Shareholders May Want To Dig Deeper Than Statutory Profit", "desc": null, "date": "21/02/2024", "link": "news.google.com/articles/CBMiiwFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1hbWduL2FtZ2VuL25ld3MvYW1nZW5zLW5hc2RhcWFtZ24tc2hhcmVob2xkZXJzLW1heS13YW50LXRvLWRpZy1kZWVwZXItdGhhbi1z0gGPAWh0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvdXMvcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbmFzZGFxLWFtZ24vYW1nZW4vbmV3cy9hbWdlbnMtbmFzZGFxYW1nbi1zaGFyZWhvbGRlcnMtbWF5LXdhbnQtdG8tZGlnLWRlZXBlci10aGFuLXMvYW1w?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdkakZCVjBobVZuUmFhbFkyVFJDSEFSajJBaWdCTWdZQkFvYlZnQXc=-w200-h112-p-df", "media": "Simply Wall St", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (AMGN) Q4 Earnings Top, Horizon Drugs Drive Sales", "desc": null, "date": "07/02/2024", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzIyMjI2MDkvYW1nZW4tYW1nbi1xNC1lYXJuaW5ncy10b3AtaG9yaXpvbi1kcnVncy1kcml2ZS1zYWxlc9IBYWh0dHBzOi8vd3d3LnphY2tzLmNvbS9hbXAvc3RvY2svbmV3cy8yMjIyNjA5L2FtZ2VuLWFtZ24tcTQtZWFybmluZ3MtdG9wLWhvcml6b24tZHJ1Z3MtZHJpdmUtc2FsZXM?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZUMlpMVm1sTk4zaG5RMDlwVFJDeUFSaWJBaWdCTWdhUmNZaUlwZ2c=-w200-h112-p-df", "media": "Zacks Investment Research", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Why the Market Dipped But Amgen (AMGN) Gained Today", "desc": null, "date": "11/03/2024", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy93aHktbWFya2V0LWRpcHBlZC1hbWdlbi1hbWduLTIxNTAxNzk0MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXdSR2xPVjFCRVh6aERUVzkyVFJEZEFSamtBU2dCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Can Amgen (AMGN) Keep the Beat Streak Alive in Q4 Earnings?", "desc": null, "date": "29/01/2024", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzIyMTY5MDgvY2FuLWFtZ2VuLWFtZ24ta2VlcC10aGUtYmVhdC1zdHJlYWstYWxpdmUtaW4tcTQtZWFybmluZ3PSAWVodHRwczovL3d3dy56YWNrcy5jb20vYW1wL3N0b2NrL25ld3MvMjIxNjkwOC9jYW4tYW1nZW4tYW1nbi1rZWVwLXRoZS1iZWF0LXN0cmVhay1hbGl2ZS1pbi1xNC1lYXJuaW5ncw?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNUtkMGt6T1dKU05tWTJXR0ZMVFJDeUFSaWJBaWdCTWdNQnNBQQ=-w200-h112-p-df", "media": "Zacks Investment Research", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "June 2025 Options Now Available For Amgen (AMGN)", "desc": null, "date": "12/03/2024", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvanVuZS0yMDI1LW9wdGlvbnMtbm93LWF2YWlsYWJsZS1mb3ItYW1nZW4tYW1nbtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXpkMkpNUVdSdmNXSmplazgwVFJDM0FSaVRBaWdCTWdPQlFnSQ=-w200-h112-p-df", "media": "Nasdaq", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Insiders Sold US$5.8m Of Shares Suggesting Hesitancy", "desc": null, "date": "14/03/2024", "link": "news.google.com/articles/CBMihwFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1hbWduL2FtZ2VuL25ld3MvYW1nZW4taW5zaWRlcnMtc29sZC11czU4bS1vZi1zaGFyZXMtc3VnZ2VzdGluZy1oZXNpdGFuY3nSAYsBaHR0cHM6Ly9zaW1wbHl3YWxsLnN0L3N0b2Nrcy91cy9waGFybWFjZXV0aWNhbHMtYmlvdGVjaC9uYXNkYXEtYW1nbi9hbWdlbi9uZXdzL2FtZ2VuLWluc2lkZXJzLXNvbGQtdXM1OG0tb2Ytc2hhcmVzLXN1Z2dlc3RpbmctaGVzaXRhbmN5L2FtcA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdkakZCVjBobVZuUmFhbFkyVFJDSEFSajJBaWdCTWdZQkFvYlZnQXc=-w200-h112-p-df", "media": "Simply Wall St", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Top Research Reports for NVIDIA, Visa & Amgen", "desc": null, "date": "28/02/2024", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy90b3AtcmVzZWFyY2gtcmVwb3J0cy1udmlkaWEtdmlzYS0xODQyMDA2NDMuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUtlaTFmT1dOVlpqSjVOa2d0VFJDeUFSaWJBaWdCTWdhQkk0Z3V6UU0=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Mark Vickery", "sentiment": "positive"}, {"title": "Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs", "desc": null, "date": "26/02/2024", "link": "news.google.com/articles/CBMimwFodHRwczovL21hcmtldHMuYnVzaW5lc3NpbnNpZGVyLmNvbS9uZXdzL3N0b2Nrcy9hbWdlbi1zLXVwY29taW5nLWNhdGFseXN0cy1pbi0yMDI0LXNldC10by11bmxvY2stbXVsdGktYmlsbGlvbi1kb2xsYXItbWFya2V0cy1zYXlzLWdvbGRtYW4tc2FjaHMtMTAzMzEwNDEyONIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVJlbmxKYlVnd01YZGpjREpYVFJEQ0FSaURBaWdCTWdhQmdZb2t4Z1E=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen (NASDAQ:AMGN) Slips as Obesity Drugs Take Center Stage - TipRanks.com", "desc": null, "date": "05/02/2024", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vd3d3LnRpcHJhbmtzLmNvbS9uZXdzL2FtZ2VuLW5hc2RhcWFtZ24tc2xpcHMtb2Jlc2l0eS1kcnVncy10YWtlLWNlbnRlci1zdGFnZdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTBRVTFtTVdOcGRIcFFiWFZuVFJDbEFSaXhBaWdCTWdZQkFvcE13UVE=-w200-h112-p-df", "media": "TipRanks", "site": null, "reporter": "Steve Anderson", "sentiment": "negative"}, {"title": "AMGN: Analyzing 3 Biotech Stocks for 2024 Gain Potential", "desc": null, "date": "05/02/2024", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2FtZ24tdnJ0eC1hbGtzLW52by1hbmFseXppbmctMy1iaW90ZWNoLXN0b2Nrcy1mb3ItMjAyNC1nYWluLXBvdGVudGlhbC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXVkRlV0Y0c1TFdtbzVXbU5RVFJDM0FSaVRBaWdCTWdhQllwUnVvUWc=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Kritika Sarmah", "sentiment": "negative"}, {"title": "Amgen analysts boost target price on obesity drug data outlook", "desc": null, "date": "03/01/2024", "link": "news.google.com/articles/CBMihQFodHRwczovL3d3dy5wcm9hY3RpdmVpbnZlc3RvcnMuY29tL2NvbXBhbmllcy9uZXdzLzEwMzc0MjMvYW1nZW4tYW5hbHlzdHMtYm9vc3QtdGFyZ2V0LXByaWNlLW9uLW9iZXNpdHktZHJ1Zy1kYXRhLW91dGxvb2stMTAzNzQyMy5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDJVMVpTV0ZreVdWaFlXbkJzVFJDWkFSaktBaWdCTWdZQkU0cE93UVE=-w200-h112-p-df", "media": "Proactive Investors USA", "site": null, "reporter": "Angela Harmantas", "sentiment": "negative"}, {"title": "AMGN vs. LLY: Which Biotech Stock Is a Better Buy Right Now?", "desc": null, "date": "15/02/2024", "link": "news.google.com/articles/CBMiZmh0dHBzOi8vd3d3LmJhcmNoYXJ0LmNvbS9zdG9yeS9uZXdzLzI0MTExMzk1L2FtZ24tdnMtbGx5LXdoaWNoLWJpb3RlY2gtc3RvY2staXMtYS1iZXR0ZXItYnV5LXJpZ2h0LW5vd9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTJNVmg2YlU0d1JFVndSME5ZVFJDNkFSaVBBaWdCTWdB=-w200-h112-p-df", "media": "Barchart", "site": null, "reporter": "Sushree Mohanty", "sentiment": "negative"}, {"title": "AMGEN TO HOST CONFERENCE CALL ON RARE DISEASE", "desc": null, "date": "19/02/2024", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hbWdlbi1ob3N0LWNvbmZlcmVuY2UtY2FsbC1yYXJlLTIxMDAwMDc5MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUNNMU14WjJ0clVsOWhVVWhSVFJDb0FSaXNBaWdCTWdhWm81UnF1UVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza", "desc": null, "date": "11/01/2024", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy94ZXJpcy14ZXJzLWxpY2Vuc2luZy1kZWFsLWFtZ2VuLTEzMzAwMDEyNC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNUpibkpOYUc0M1RIRXhUVFphVFJDeUFSaWJBaWdCTWdNSkFBUQ=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and AstraZeneca", "desc": null, "date": "15/01/2024", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy96YWNrcy1hbmFseXN0LWJsb2ctaGlnaGxpZ2h0cy1lbGktMTA1MDAwMTIyLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFTbWxZWTJKcVVEQm9TVmxPVFJDeUFSaWJBaWdCTWdhQnNvb3R3UVU=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Amgen (AMGN) Ascends But Remains Behind Market: Some Facts to Note", "desc": null, "date": "19/03/2024", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzIyNDMwNzcvYW1nZW4tYW1nbi1hc2NlbmRzLWJ1dC1yZW1haW5zLWJlaGluZC1tYXJrZXQtc29tZS1mYWN0cy10by1ub3Rl0gFsaHR0cHM6Ly93d3cuemFja3MuY29tL2FtcC9zdG9jay9uZXdzLzIyNDMwNzcvYW1nZW4tYW1nbi1hc2NlbmRzLWJ1dC1yZW1haW5zLWJlaGluZC1tYXJrZXQtc29tZS1mYWN0cy10by1ub3Rl?hl=en-US&gl=US&ceid=US%3Aen", "img": null, "media": "Zacks Investment Research", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "The Zacks Analyst Blog Highlights NVIDIA, Visa, Amgen, Chubb and PACCAR", "desc": null, "date": "29/02/2024", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy96YWNrcy1hbmFseXN0LWJsb2ctaGlnaGxpZ2h0cy1udmlkaWEtMTQxNTAwMTcxLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHljMWgwWDNoc1VqSktWRE5mVFJDeUFSaWJBaWdCTWdZQjFZNkZSZ1U=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Why Investors Are Eyeing Amgen Inc (AMGN): The Key Drivers of Market Outperformance and Growth Potential", "desc": null, "date": "27/03/2024", "link": "news.google.com/articles/CBMijAFodHRwczovL3d3dy5ndXJ1Zm9jdXMuY29tL25ld3MvMjM5ODUzMS93aHktaW52ZXN0b3JzLWFyZS1leWVpbmctYW1nZW4taW5jLWFtZ24tdGhlLWtleS1kcml2ZXJzLW9mLW1hcmtldC1vdXRwZXJmb3JtYW5jZS1hbmQtZ3Jvd3RoLXBvdGVudGlhbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVVhVGhaUWxOcWVFNXdiRXBSVFJESUFSajhBU2dCTWdhaFpKS3RNUWM=-w200-h112-p-df", "media": "GuruFocus.com", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "3 Biotech Stocks to Buy on the Dip: March 2024", "desc": null, "date": "27/03/2024", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyNC8wMy8zLWJpb3RlY2gtc3RvY2tzLXRvLWJ1eS1vbi10aGUtZGlwLW1hcmNoLTIwMjQv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVZaVGxCUWxSMUxXZFdhWEZFVFJDb0FSaXNBaWdCTWdNQlV3dw=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Ian Cooper", "sentiment": "negative"}, {"title": "PBYI vs. AMGN: Which Stock Should Value Investors Buy Now?", "desc": null, "date": "09/02/2024", "link": "news.google.com/articles/CBMiYGh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzIyMjQyNTUvcGJ5aS12cy1hbWduLXdoaWNoLXN0b2NrLXNob3VsZC12YWx1ZS1pbnZlc3RvcnMtYnV5LW5vd9IBZGh0dHBzOi8vd3d3LnphY2tzLmNvbS9hbXAvc3RvY2svbmV3cy8yMjI0MjU1L3BieWktdnMtYW1nbi13aGljaC1zdG9jay1zaG91bGQtdmFsdWUtaW52ZXN0b3JzLWJ1eS1ub3c?hl=en-US&gl=US&ceid=US%3Aen", "img": null, "media": "Zacks Investment Research", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Investors' Focus Around Amgen's Obesity Drug Data Shadows Better Than Expected Q4 Earnings", "desc": null, "date": "07/02/2024", "link": "news.google.com/articles/CBMilAFodHRwczovL21hcmtldHMuYnVzaW5lc3NpbnNpZGVyLmNvbS9uZXdzL3N0b2Nrcy9pbnZlc3RvcnMtZm9jdXMtYXJvdW5kLWFtZ2VuLXMtb2Jlc2l0eS1kcnVnLWRhdGEtc2hhZG93cy1iZXR0ZXItdGhhbi1leHBlY3RlZC1xNC1lYXJuaW5ncy0xMDMzMDQyNjIw0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW9PVXRCT1ZoNGJUSmFRMm93VFJEQ0FSaURBaWdCTWdZWmM0NXNNUVk=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen: Q4 Earnings Snapshot", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMiNGh0dHBzOi8vcXouY29tL2FtZ2VuLXE0LWVhcm5pbmdzLXNuYXBzaG90LTE4NTEyMzE4NDHSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDNOMVJFZDFaV1VUUkplVmx4VFJDcEFSaXJBaWdCTWdB=-w200-h112-p-df", "media": "Quartz", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Buffett's Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating", "desc": null, "date": "25/03/2024", "link": "news.google.com/articles/CBMihwFodHRwczovL21hcmtldHMuYnVzaW5lc3NpbnNpZGVyLmNvbS9uZXdzL3N0b2Nrcy9idWZmZXR0cy1iYWNrZG9vci1idXlzLTMtc3RvY2tzLWhpcy1zZWNyZXQtcG9ydGZvbGlvLWlzLXF1aWV0bHktYWNjdW11bGF0aW5nLTEwMzMxOTQyNzjSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNHdVbFEwZW5obk5XMDVNbkpRVFJDb0FSaXJBaWdCTWdB=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": "Rich Duprey", "sentiment": "positive"}, {"title": "Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields", "desc": null, "date": "13/03/2024", "link": "news.google.com/articles/CBMinQFodHRwczovL21hcmtldHMuYnVzaW5lc3NpbnNpZGVyLmNvbS9uZXdzL3N0b2Nrcy93YWxsLXN0cmVldC1zLW1vc3QtYWNjdXJhdGUtYW5hbHlzdHMtdmlld3Mtb24tMy1oZWFsdGgtY2FyZS1zdG9ja3MtZGVsaXZlcmluZy1oaWdoLWRpdmlkZW5kLXlpZWxkcy0xMDMzMTU5MTk50gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHdWRU5oUTNWRVdtUTVXR1JPVFJEQ0FSaURBaWdCTWdZQmdvd0ROUVk=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Noteworthy ETF Outflows: XLV, DHR, PFE, AMGN", "desc": null, "date": "26/02/2024", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvbm90ZXdvcnRoeS1ldGYtb3V0Zmxvd3M6LXhsdi1kaHItcGZlLWFtZ27SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTNUR3gxVjNKaVVuRk1ObmhxVFJDM0FSaVRBaWdCTWdNSkF3QQ=-w200-h112-p-df", "media": "Nasdaq", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen Inc. (NASDAQ:AMGN) Q4 2023 Earnings Call Transcript", "desc": null, "date": "07/02/2024", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3Lmluc2lkZXJtb25rZXkuY29tL2Jsb2cvYW1nZW4taW5jLW5hc2RhcWFtZ24tcTQtMjAyMy1lYXJuaW5ncy1jYWxsLXRyYW5zY3JpcHQtMTI1NDkyNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW9YMHBhZDNJNE1VUXlXblpaVFJDb0FSaXNBaWdCTWdhaE1vWUxtZ2s=-w200-h112-p-df", "media": "Insider Monkey", "site": null, "reporter": "Insider Monkey", "sentiment": "negative"}, {"title": "U.S. Senator Tommy Tuberville Just Reported a Sale of $AMGN stock", "desc": null, "date": "15/02/2024", "link": "news.google.com/articles/CBMid2h0dHBzOi8vd3d3LmludmVzdGluZy5jb20vbmV3cy9zdG9jay1tYXJrZXQtbmV3cy91cy1zZW5hdG9yLXRvbW15LXR1YmVydmlsbGUtanVzdC1yZXBvcnRlZC1hLXNhbGUtb2YtYW1nbi1zdG9jay0zMzA1MjI10gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHhaMDU0UWxBM09UbEdRM054VFJDM0FSaVRBaWdCTWdZSmRJaElyZ1U=-w200-h112-p-df", "media": "Investing.com", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Amgen's Diversified Portfolio To Drive Long-Term Growth, Though Uncertainties Loom, Analyst Says - Amgen", "desc": null, "date": "28/03/2024", "link": "news.google.com/articles/CBMimQFodHRwczovL3d3dy5iZW56aW5nYS5jb20vYW5hbHlzdC1yYXRpbmdzL2FuYWx5c3QtY29sb3IvMjQvMDMvMzc5OTE5OTUvYW1nZW5zLWRpdmVyc2lmaWVkLXBvcnRmb2xpby10by1kcml2ZS1sb25nLXRlcm0tZ3Jvd3RoLXRob3VnaC11bmNlcnRhaW50aWVzLWxvb20tYW7SAS1odHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvMzc5OTE5OTU?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXdjbVF0VlZKRkxYZHRORXQwVFJDM0FSaVRBaWdCTWdrQkVJZ2x4cVRBOXdB=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Vandana Singh", "sentiment": "positive"}, {"title": "Cathie Wood's Ark Invest Liquidates $15.8M Worth Of ProShares Bitcoin Strategy ETF Units - Amgen (NASDAQ:", "desc": null, "date": "16/01/2024", "link": "news.google.com/articles/CBMijwFodHRwczovL3d3dy5iZW56aW5nYS5jb20vbWFya2V0cy9lcXVpdGllcy8yNC8wMS8zNjY1Mzc4Ni9jYXRoaWUtd29vZHMtYXJrLWludmVzdC1saXF1aWRhdGVzLTE1LThtLXdvcnRoLW9mLXByb3NoYXJlcy1iaXRjb2luLXN0cmF0ZWd5LWV0Zi11bml0c9IBLWh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hbXAvY29udGVudC8zNjY1Mzc4Ng?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUVaVGRCVFdReFRWcGlPVEJNVFJDM0FSaVRBaWdCTWdZWmVJeHByZ1k=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Apple Sinks After Wall Street Titan Pulls Magnificent 7 Stock From Conviction List Apple Sinks After Wall", "desc": null, "date": "01/03/2024", "link": "news.google.com/articles/CBMimAFodHRwczovL3d3dy5iZW56aW5nYS5jb20vYW5hbHlzdC1yYXRpbmdzL2FuYWx5c3QtY29sb3IvMjQvMDMvMzc0MjM4NzcvYXBwbGUtc2lua3MtYWZ0ZXItd2FsbC1zdHJlZXQtdGl0YW4tcHVsbHMtbWFnbmlmaWNlbnQtNy1zdG9jay1mcm9tLWNvbnZpY3Rpb24tbGlzdNIBLWh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hbXAvY29udGVudC8zNzQyMzg3Nw?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVlNMW90UTFaT2FWY3dRVzlZVFJDM0FSaVRBaWdCTWdhQkVZWnBNUVk=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Chris Katje", "sentiment": "negative"}, {"title": "Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs", "desc": null, "date": "25/01/2024", "link": "news.google.com/articles/CBMiZGh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyNC8wMS9zdG9ja3MtdG8td2F0Y2gtMy1jb21wYW5pZXMtd29ya2luZy1vbi1uZXh0LWdlbi13ZWlnaHQtbG9zcy1kcnVncy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXhVRTV1ZVROalgyeFJaM05FVFJDb0FSaXNBaWdCTWdZbEJZak9KUVU=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Larry Ramer", "sentiment": "negative"}]